Buzz on the Street Show: Numinus Wellness (TSX-V: NUMI) 2020 Operational Plans to Scale – Financialbuzz.com

FinancialBuzz.coms latest Buzz on the Street Show: Featuring Our Corporate News Recap on Numinus Announces 2020 Operational Plans to Scale.

Numinus Wellness Inc. (TSX-V: NUMI) is pleased to report its near-term goals to advance our mission to address the universal desire to heal.

Numinus is a Vancouver-based health care company helping to support the universal desire to heal and be well. Numinus believes the societal costs of mental illness, addictions, trauma and unmet human potential are much too high. New approaches and new ways of thinking are required to supplement existing options, including the application of psychedelic assisted therapies when approved by regulators.Numinus Wellnessoperates a stand-alone centre offering patients integrative health solutions to help heal, connect and grow. Psychedelic assisted therapies will be part of this offering but will only be available for treatment once approved by regulators and governing bodies a process Numinus is helping to support.Numinus R&Dis creating partnerships with leading research groups to advance practice and understanding in the space.Numinus Bioscienceis licensed by Health Canada to test, sell, distribute, and eventually conduct research on psychedelic substances. Sustainable cannabis revenue driven by testing operations provides us a foundation for growth.

Recent data indicates that psychedelic products are gaining recognition. Several crucial data points have been observed in recent studies, pointing to potential benefits of such products. For example, according to a recentstudy, a single dose of psilocybin (naturally occurring psychedelic compound) can make symptoms of depression significantly improve. The randomized controlled trial compared single-dose psilocybin with single-dose niacin in conjunction with psychotherapy in participants with cancer-related psychiatric distress. Results suggested that psilocybin-assisted psychotherapy facilitated improvements in psychiatric and existential distress, quality of life, and spiritual well-being up to seven weeks prior to the crossover. At the 6.5-month follow-up, after the crossover, 60-80% of participants continued to meet criteria for clinically significant antidepressant or anxiolytic responses. Following recent studies, and the FDAs decision to approve the first ketamine-based psychedelic medicine from Johnston & Johnston to treat depression, psychedelic products may follow cannabis on a similar path to the legalization and finally breaking free of their established stigma.

The growing awareness of health benefits associated with cannabidiol (CBD) products has pushed the market into mainstream retail. And yet, despite its growth of recent years, it is important to remember that cannabis products are still illegal in the U.S on the federal level. This regulatory obstacle is one of the last remaining difficulties that has been holding the industry back to a significant degree. There is plenty of room for growth here, believes Confident Cannabis VP of Growth & MarketingBrad Bogusaccording to a report byCivilized. CBD is sort of stuck in between prohibition era policies and federal acceptance. We just saw the first cannabis derived FDA approved medication make its way onto the market, which is a CBD medication. Where it goes from here in the world of Big Pharma is hard to say, but the direction will be up, in some velocity. Seniors are more keen to try a CBD product over a THC product, so even on the regular non-pharmaceutical market, CBD will still snag a good portion of untapped market share. International trade of source material is another big advantage of the CBD market, to help it grow.

For more information, please visit: Numinus Wellness Inc.

For more corporate news on Numinus Wellness Inc., check out the Buzz on the Street

About Buzz on the Street: One of FinancialBuzz.coms latest corporate and financial news shows, covering the latest trending stock market news. Buzz on the Street looks to become a leader in corporate video news dissemination. Buzz on the Street is 100% original content, brought to you by Financial Buzz Media.

Read more:
Buzz on the Street Show: Numinus Wellness (TSX-V: NUMI) 2020 Operational Plans to Scale - Financialbuzz.com

Agape Treatment Center Now Offers Mental Health and Addiction Treatment During the Covid-19 Pandemic – Press Release – Digital Journal

This press release was orginally distributed by ReleaseWire

Fort Lauderdale, FL -- (ReleaseWire) -- 09/22/2020 -- Individuals struggling to access mental health treatment and drug rehab during Covid-19 have been given a lifeline at a Florida-based addiction rehabilitation facility, Agape Treatment Center.

The novel Corona Virus has undoubtedly brought on a lot of challenges. According to reports from the Centers for Disease Control (CDC), 40% of adults reported during late June that they were struggling with their mental health or substance use. Statistics also indicate that online alcohol sales in the United States increased by 243% since the start of the pandemic. Sadly, the social distancing, isolation and stay-at-home measures implemented to contain the spread of the disease have made it quite difficult for those with addiction and mental health issues to access treatment.

Agape Treatment Center is open and accepting admissions to assist individuals who have turned to drugs or alcohol to cope with the stress, worry, and fear associated with this unprecedented time. The facility offers comprehensive psychological, sociological, and spiritual solutions to help individuals get back on the path of sobriety. Their programs include medication assisted treatments, outpatient programming, intensive outpatient programming and individual therapy.

The facility is also fully equipped to handle mental health disorders as a dual diagnosis treatment facility for co-occurring disorders. Therapy is administered in a serene therapeutic environment by experienced licensed clinicians, therapists, and addiction professionals.

Founder and CEO of Agape Treatment Center, George Mavrookas, said: "We are so blessed to be able to help other alcoholics and addicts continue to fight a mental health battle while the world battles a pandemic. Agape Treatment Center is proud to serve on the front line and continue to help those who need our services during this time."

Aside from the evidenced-based programs offered at the facility, clients can bolster their treatment with amenities such as integrative medicine, nutrition therapy, chiropractic care, massage therapy and yoga. Agape Treatment Center is accredited by the Joint Commission (JCAHO), the Agency for Healthcare Administration (AHCA), verified by PsychologyToday, a member of the National Association of Addiction Treatment Providers (NAATP), and monitored by LegitScript.

For further information or to access addiction help, call (954) 908-6404 or visit the company's website at https://www.agapetc.com.

About Agape Treatment CenterAgape Treatment Center is an addiction rehabilitation center that embraces a universal, unconditional love that transcends and serves regardless of circumstances. The facility provides individuals all over the country with the opportunity to achieve the gift of lasting sobriety if you struggle with addiction or co-occurring disorders.

Media contact: George MavrookasEmail: gmavrookas@agapetc.com (954) 908-6404

For more information on this press release visit: http://www.releasewire.com/press-releases/agape-treatment-center-now-offers-mental-health-and-addiction-treatment-during-the-covid-19-pandemic-1304948.htm

Read the rest here:
Agape Treatment Center Now Offers Mental Health and Addiction Treatment During the Covid-19 Pandemic - Press Release - Digital Journal

A message from the health center: complementary and alternative medicines – The Lion’s Roar Newspaper

Western medicine, also known as traditional medicine, is the familiar system in which healthcare providers treat symptoms and diseases using drugs, radiation and/or surgery. Complementary and alternative medicine (CAM) is a term used for medical products and practices that are typically not part of traditional medicine or included in standard medical care. The terms complementary and alternative both refer to treatments like herbal remedies or acupuncture. However, complementary medicine is when these therapies are used along with traditional western medicine practices. Alternative medicine refers to using alternative approaches instead of using traditional western medical approaches. Some practices of CAM include massage therapy, acupuncture, acupressure, Tai Chi, aromatherapy, herbal medicine and chiropractic.

When it comes to CAM, there are four major alternative medical systems that were developed by the National Center for Complementary and Alternative Medicine (NCCAM) in 2000. These four alternative medical systems include:

1. Mind-body interventions: involve using specific techniques to boost the minds capacity to influence bodily function and enhance health (i.e. meditation and yoga)

2. Biologically-based treatment: the use of substances found in nature (i.e. herbs, foods and vitamins)

3. Manipulative and body-based methods: focuses on applying specific treatments to address health issues (i.e. reflexology and chiropractic)

4. Energy therapies: based on the idea that energy fields surround and penetrate the human body (i.e. therapeutic touch and Reiki)

Advertisement

As you can see from the four major alternative medical systems, CAM is used for physical, mental and spiritual health. In addition, CAM is widely used today and is increasing in popularity. In the United States, complementary and alternative medicine is used by about 38% of adults and 12% of children, according to John Hopkins Medical.

If you are interested in integrating or learning more about CAM, ask your primary care provider if integrated therapy is right for you. You can also ask your primary care provider if they can provide you with recommendations and/or contact your local hospital or medical school as they often keep lists of integrative medicine practitioners in the area.

Advertisement

Go here to read the rest:
A message from the health center: complementary and alternative medicines - The Lion's Roar Newspaper

Fall and Chinese Medicine: How to let go of summer – Shoreline Times

Fall the air gets crisper, the days shorter, we finish up projects started in the spring and prepare for new ones. We harvest the fruits of summers heat apples and mums, pumpkins and corn.

It is time to let go of long summer days, open windows, vacations, cookouts and swims in the sea.

One compelling nuance of Chinese Medicine is the awareness of the connection between the seasons and our organ systems, emotions and spirit. The lungs, which is the organ that predominates in autumn, must be healthy in order to protect the body from colds and flu, allergies, asthma, bronchitis and decreased immune function.

Each organ has an associated emotion and the lung is connected with sadness and grief. Sadness that has run well past its normal course can weaken the lungs, and unacknowledged or suppressed grief will interrupt its normal function. Like all of the other emotions, a Chinese Medical perspective gives us a different, more expansive and even poetic view of sadness, letting go, and grief.

The process of grief is closely tied to a sense of precious beauty and completion whether we are dealing with the end of a loved ones life, the season of summer or perhaps a job, relationship or dwelling we had our heart set on. It makes us return our focus to what we do have.

Lao Tzu, the famous Chinese philosopher writes, Only in losing do we gain.

A good practitioner of Chinese Medicine will strengthen the lungs with a variety of techniques. Needling a point on the inner side of the arm about two inches above the wrist can help to release constrained emotions. Specific points on the back help to strengthen lung function. Cupping (remember those dark purple spots on Michael Phelps during the Olympics?) removes dampness. Burning the herb mung wort (moxa) over certain parts of the body can strengthen lung function. It is best for someone who is prone to colds, flu and allergies to have these issues addressed with treatments in the spring and summer before the fall and winter when they become more vulnerable.

In ancient China it was the physicians job to keep their patients healthy. When a patient became sick and died a lantern was hung outside the doctors door to let the village know.

Chinese Medicine, different in approach from the Western medical perspective of disease and its treatment, is neither better nor worse. The two work well together and often complement the others way of restoring health. I like to think of Eastern Medicine as integrative rather than alternative.

As I have said before, it is most likely the oldest and most widely used medicine in the world. The body of knowledge from which it is derived is thousands of years old and vast. The fact that it is practiced in just about every New York City hospital today is very good news. It means we have the beginning of a dialogue which will eventually result in a much-needed improvement to our mainstream healthcare system. I am sure, especially in these times, many will agree that this is a good thing, indeed.

Continued here:
Fall and Chinese Medicine: How to let go of summer - Shoreline Times

How to Reduce Cortisol and Turn Down the Dial on Stress – Health Essentials from Cleveland Clinic

Feeling stressed out and exhausted? You might be tempted to blame the infamous stress hormone known as cortisol.

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services.Policy

Theres a lot of information and theories about cortisol floating around. For instance: You can lower cortisol levels with a nice cup of tea or even better chocolate.

Alas, its not quite that simple. (Is it ever?) Nutrition is absolutely important for coping with stress and supporting your mood, but theres no single food thats going to do it all, says integrative medicine doctor Yufang Lin, MD. You have to look at the whole lifestyle picture.

Taking everything like that into account is more important than ever right now as we deal not just with the stress from the ongoing coronavirus pandemic, but the emotional ups and downs that come with it.

Heres her big-picture advice for keeping cortisol and the rest of your body and mind in balance.

Cortisol is one of several hormones the body produces naturally. Cortisol levels do go up when youre stressed. But it doesnt deserve its bad rap.

Cortisol supports overall health, Dr. Lin says. It helps us wake up, gives us energy during the day and lowers at night to help us sleep and rest.

The problem arises when chronic stress keeps cortisol levels high for the long haul. High cortisol levels over weeks or months can lead to inflammation and a host of mental and physical health problems, from anxiety to weight gain to heart disease.

Yes, no and maybe. Some research suggests that foods like tea, chocolate and fish oils might lower cortisol. But such studies tend to be small and not very conclusive, Dr. Lin says.

Youre unlikely to balance cortisol levels by adding anchovies to your pizza or scarfing a block of chocolate, she says. But good nutrition can make a difference.

Cortisol interacts with neurotransmitters, the chemical messengers that send signals in the brain. Neurotransmitters play an important role in mood. And cortisol isnt the only compound that influences them. To make those neurotransmitters, you need all the raw ingredients: vitamins, minerals and other nutrients, Dr. Lin says.

The best way to get them is with a balanced, plant-heavy diet, such as the Mediterranean diet, she adds. A healthy diet is the underpinning of stress management.

A balanced meal plan can ensure youre getting the nutrients your body needs. And talk to your doctor about taking a basic multivitamin. Its a good insurance policy to make sure youre not deficient in any vitamins, Dr. Lin says.

The supplement aisle at the natural foods store is hardly a one-way ticket to a stress-free life. But some items may help keep cortisol levels in a healthy range, Dr. Lin says. Research suggests these herbs and natural supplements might lower stress, anxiety and/or cortisol levels:

While some herbs might help lower cortisol levels naturally, you dont want to swallow everything in sight, Dr. Lin says. Teas like lemon balm and chamomile are quite safe. But if youre thinking about trying herbs in supplement form, talk to a trained provider first.

Dr. Lin stresses that a big-picture approach is key to maintaining healthy cortisol levels and feeling less stressed. These go-to strategies are good for the body and the mind.

Exercise benefits health from head to toe. So its no surprise that it helps with stress relief, too, possibly by reducing cortisol levels. Studies show, for instance, that exercise can bring down cortisol levels in the elderly and in people with major depressive disorder.

Almost nothing beats a good nights sleep. When youre not sleeping well, you tend to be more anxious, irritable and stressed, Dr. Lin says. Like exercise, sleep is important for health in all sorts of ways including managing stress and keeping cortisol in check.

Sleep deprivation may increase cortisol levels. The increased cortisol can impair memory, contribute to weight gain and even accelerate the aging process. In other words: Dont skimp on shut-eye.

Spending time in the great outdoors is a great way to lower cortisol and calm your brain. The practice of forest bathing essentially, hanging out in the woods and breathing the forest air can reduce cortisol levels and lower stress. (Just pack your bug spray, so the mosquitoes dont stress you out.)

While they might not be something youve ever considered, practices like yoga, tai chi, qi gong, mindfulness meditation and breathing exercises can be great stress busters and a lot of skeptics have turned to converts. Research has found, for example, that mindfulness-based stress reduction therapy can lower cortisol and feelings of stress. And yoga can bring down high cortisol levels, heart rate and blood pressure.

When it comes to de-stressing, cortisol is just one piece of the puzzle, Dr. Lin adds. No one food or pill can deliver you to blissful calm. But healthy choices can set your body up for low-stress success.

See the original post:
How to Reduce Cortisol and Turn Down the Dial on Stress - Health Essentials from Cleveland Clinic

Victory through Visualisation – The New Indian Express

What if you have the power to change your life and health just by changing how your mind thinks and feels? Vitamin V is not a vitamin found in any fruit, vegetable, spice or supplement. Its a vitamin within our power to cultivate and practice. Its called Visualisation, and by far, it stands to be one of the most powerful drugs we have known in our practice, even beyond medicine. It can be applied to any area of your lifehealth, finance, family, relationships, personal growth, jobs etc.

Mind, thoughts, feelings and gene expression Your mind controls your gene expression or the way genes express themselves. Genes control everything from the way you look, your complexion, behaviour and habits, and a whole lot more. Each of us has a set of good and bad genes and these can either be up-regulated (turned on) or down-regulated (turned off).

Factors that change gene expression could be internal or external. Speaking about internal factors, it could be wrong eating patterns, sedentary lifestyle, poor sleeping habits, smoking, and to a large extent, our emotions, including traumatic incidents that the person might have faced. All these factors can change the expression of genes. Emotions have the power to turn on and turn off certain genes.

In this case, where our mind can turn on diseased genes, it can also turn off genes by simply changing the way we think, considering every human being has this power. Visualisation helps here. It lies in the power of your mind, particularly the subconscious mind. This part of the mind doesnt operate from a place of reason or logic. It operates based on what you train it to do.

The subconscious doesnt understand the difference between the real and the imagined, and when it comes to healing, preventing or managing a disease or emotional health, we can use this to our advantage. One can reprogramme the subconscious exactly the way one wants. People have known to recover from stage four cancer using this.

How to practice visualisation1. Centre yourself with deep breathing while keeping your back straight and chin parallel to the ground2. Close your eyes and imagine a black or a white canvas in front of you. It could also be a screen or a plain blue sky.3. Using your mind, paint a picture of what you want. For example, if its cancer that you want to heal, imagine sick cells dying and healthy cells thriving.4. Imagine your immune system as an army of strong soldiers protecting you5. Visualise going to a doctor for a scan and walking out of the hospital with a clean scan report6. Imagine yourself and your family smiling at this news.

Sometimes deep visualisation puts a smile on your face. If it happens, let it. Once the visualisation is done, surrender what you visualised. Dont think about it anymore. Leave it with faith. Open your eyes and let that vision float. Do it for as long as you want. Repeat daily.

Luke CoutinhoThe author is a Mumbai-based holistic lifestyle coachIntegrative Medicine

Read the original post:
Victory through Visualisation - The New Indian Express

Johnson & Johnson Celebrates Role of Scientists In Society with 2020 Dr. Paul Janssen Award for Biomedical Research, Part of the Champions of…

NEW BRUNSWICK, N.J., Aug. 20, 2020 /PRNewswire/ --Johnson & Johnson(NYSE: JNJ) today announced Lewis Cantley, Ph.D., of Weill Cornell Medicine and NewYork-Presbyterian as the winner of the 2020 Dr. Paul Janssen Award for Biomedical Research for his incisive research revealing the fundamental aspects of metabolism that have profound implications for the understanding, diagnosis and treatment of human diseases such as cancer and diabetes.

"Like all of the past Dr. Paul Janssen Award winners, and indeed like Dr. Janssen himself, Dr. Cantley challenged the status quo, asked provocative questions, and tirelessly followed his curiosity to uncover scientific insights that have led to an expanded understanding of human biology and the development of solutions that can improve people's lives," said Paul Stoffels, M.D., Vice Chairman of the Executive Committee and Chief Scientific Officer, Johnson & Johnson. "We are proud to honor the legacy of Dr. Janssen by celebrating today's research pioneers like Dr. Cantley."

Selected by an independent committee of world-renowned scientists, Cantley won for his discovery of phosphoinositide 3 kinase (PI3K), a key enzyme that promotes cell growth and division, and plays a critical role in diseases including cancer to diabetes, as well as rare diseases such as mosaicism. Hejoins 18 scientistswho have received the Dr. Paul Janssen Award since 2004, including threewho went on to win the Nobel Prize.

"I am honored to be named the winner of this year's Paul Janssen Award," said Dr. Cantley, the Meyer Director of the Sandra and Edward Meyer Cancer Center at Weill Cornell Medicine and NewYork-Presbyterian/Weill Cornell Medical Center and a professor of cancer biology at Weill Cornell Medicine. "I share Dr. Janssen's passion for scientific exploration, and I'm pleased to receive this recognition of the work done in my laboratory."

The Award is part of Johnson & Johnson's Champions of Science initiative to fuel public engagement, support and trust in science.

"The critical role of science in our society has been brought to the forefront by the COVID-19 pandemic," says Seema Kumar, Vice President, Innovation, Global Health and Science Policy Communication, Johnson & Johnson. "Today more than ever, we look to science to provide answers and new solutions to maintain our health and solve complex medical challenges. By sharing the stories of scientists across generations and geographies, from students to those at the pinnacle of their career, like the winners of the Dr. Paul Janssen Award, we hope to engage more people in becoming ardent champions of science."

Dr. Cantley's work will be celebrated during the Champions of Science: Dr. Paul Janssen Award 2020 webcast, open to the public, on Wednesday, September 16, 2020, at 12:30 p.m. ET via Johnson & Johnson's page on LinkedIn. This unique virtual celebration will honor Dr. Cantley, showcase young innovators at the start of their STEM journeys, and engage the public in a conversation about the importance of science in society.

In addition, Dr. Cantley will be honored at a virtual scientific symposium, presented in collaboration with the New York Academy of Sciences, on September 16, 2020, at 9 a.m. ET. The event will feature presentations from leading experts on the biology of cellular metabolism and its role in human health and disease, including Matthew Vander Heiden, M.D., Ph.D. of the Koch Institute for Integrative Cancer Research atMIT, Karen Vousden, Ph.D., of the Francis Crick Institute, and Ulrike Philippar, Ph.D., of Janssen Pharmaceuticals. Click here to register or for additional information.

"Dr. Cantley's discoveries have transformed our understanding of how human cellular metabolism works," said Richard P. Lifton, M.D., Ph.D., President of The Rockefeller University and Dr. Paul Janssen Award committee chair. "The discovery of PI3K has led to better treatment of a range of diseases, bringing hope to countless patients around the world."

"The research of Dr. Cantley has been illustrative in understanding the metabolic properties of malignant cells and in informing more targeted approaches in cancer treatment," said Peter Lebowitz, M.D., Ph.D., Global Therapeutic Area Head, Oncology, Janssen Research & Development, LLC. "Dr. Cantley's contributions have spurred innovations in oncology that have ultimately benefited many patients, and he has inspired many scientists to progress new research strategies."

About Champions of Science Science touches our lives in every imaginable way. From antibiotics and telecommunications, to genomics, precision medicine and 3D printing, science has improved the human condition leading to longer, healthier, happier lives for people all over the world. To continue to advance, science needs champions! As a global healthcare company, The Johnson & Johnson Family of Companies is uniquely positioned to champion the role of science in society. Champions of Science is a multi-faceted public engagement initiative to convene and catalyze champions of science and engage people of all generations and backgrounds to see the unlimited opportunities that science brings. To learn more, visit http://www.jnj.com/champions-of-science

About the Dr. Paul Janssen Award for Biomedical Research Dr. Paul Janssen was one of the 20th century's most gifted and passionate researchers. He helped save millions of lives through his contribution to the discovery and development of more than 80 medicines, four of which remain on the World Health Organization's list of essential medicines.

The Dr. Paul Janssen Award for Biomedical Research was established by Johnson & Johnson in 2004 to honor the memory of Dr. Paul. Since its inception, the Award has recognized 18 outstanding scientists, three of whom have gone on to win the Nobel Prize for the same work. Winners are chosen by an independent selection committee of the world's most renowned scientists. The Award, which includes a $200,000 prize, is presented at ceremonies in September.

Previous winners include:

Learn more about The Dr. Paul Janssen Award at http://www.pauljanssenaward.com

About Johnson & Johnson At Johnson & Johnson, we believe good health is the foundation of vibrant lives, thriving communities and forward progress. That's why for more than 130 years, we have aimed to keep people well at every age and every stage of life. Today, as the world's largest and most broadly based health care company, we are committed to using our reach and size for good. We strive to improve access and affordability, create healthier communities, and put a healthy mind, body and environment within reach of everyone, everywhere. We are blending our heart, science and ingenuity to profoundly change the trajectory of health for humanity. To learn more, visit http://www.jnj.com

SOURCE Johnson & Johnson

http://www.jnj.com

See more here:
Johnson & Johnson Celebrates Role of Scientists In Society with 2020 Dr. Paul Janssen Award for Biomedical Research, Part of the Champions of...

What a new study reveals about cannabis and migraines – The GrowthOp

Cannabis with THC levels over 10 per cent became the strongest predictor of success in treating migraine- and headache-related pain.

For the first time, researchers have focused on dried cannabis flower as treatment for headaches and migraines.

Published in the Journal of Integrative Medicine, the study examined, in real time, the associations between different product characteristics and changes in symptom intensity following cannabisuse.

Interestingly, results showcased that flower was, indeed, effective for migraines, but the specifics of the cannabis plant (gender, age and combustion methods) may decrease effectiveness.

One key finding determined that cannabis with tetrahydrocannabinol (THC) levels over 10 per cent became the strongest predictor of success in treating migraine- and headache-related pain with cannabis.

Additionally, the C. indica strain offered greater success with individuals in the study over its C. sativa counterpart. Overall, for those seeking migraine relief and for healthcare professionals looking to treat those who have headaches, the study could be an important conversation starter for better outcomes against pain.

Results of the study offer insight into how cannabis looks to not only alleviate, but could eliminate, migraine pain for some users. With more than 94 per cent of users experiencing symptom relief within two hours, the study has brought to light deeper conversations around cannabis role in pain and quality-of-life for those experiencing headache-related disorders.

The research joins another study that looked into the prolonged use of cannabis for individuals who suffer migraines. Published in May in Brain Sciences, the study found that frequent cannabis use decreased migraine frequency.

Another study found that frequent cannabis use decreased migraine frequency. / Photo: iStock / Getty Images PlusiStock / Getty Images Plus

These findings indicate that MC [medical cannabis] results in long-term reduction of migraine frequency in more than 60 per cent of treated patients and is associated with less disability and lower anti-migraine medication intake.

Cannabis and CBD have attracted interest in migraine treatments in the last few years with organizations looking to alternative medicine to offer a needed solution for those who dont want to use opioids.

The Migraine Research Foundation gave Dr. Nathaniel Schuster from the University of California San Diego funding for his research on cannabis in 2018. Additionally, the American Headache Society and the American Migraine Foundation have both expressed the need for more research around cannabis and CBD for migraine relief.

The FreshToast.com, a U.S. lifestyle site that contributes lifestyle content and, with their partnership with 600,000 physicians via Skipta, medical marijuana information to The GrowthOp.

Want to keep up to date on whats happening in the world of cannabis?Subscribeto the Cannabis Post newsletter for weekly insights into the industry, what insiders will be talking about and content from across the Postmedia Network

Continue reading here:
What a new study reveals about cannabis and migraines - The GrowthOp

Yoga Shown to Improve Anxiety, Study Finds | NYU Langone News – NYU Langone Health

Yoga improves symptoms of generalized anxiety disorder, a condition with chronic nervousness and worry, suggesting the popular practice may be helpful in treating anxiety in some people.

Led by researchers at NYU Grossman School of Medicine, a new study found that yoga was significantly more effective for generalized anxiety disorder than standard education on stress management, but not as effective as cognitive behavioral therapy (CBT), the gold standard form of structured talk therapy that helps patients identify negative thinking for better responses to challenges.

Generalized anxiety disorder is a very common condition, yet many are not willing or able to access evidence-based treatments, says lead study author Naomi M. Simon, MD, a professor in the Department of Psychiatry at NYU Langone Health. Our findings demonstrate that yoga, which is safe and widely available, can improve symptoms for some people with this disorder and could be a valuable tool in an overall treatment plan.

For the study, 226 men and women with generalized anxiety disorder were randomly assigned to 3 groupsCBT, Kundalini yoga, or stress management education, a standardized control technique.

After three months, both CBT and yoga were found to be significantly more effective for anxiety than stress management. Specifically, 54 percent of those who practiced yoga met response criteria for meaningfully improved symptoms compared with 33 percent in the stress education group. Of those treated with CBT, 71 percent met these symptom improvement criteria.

However, after six months of follow-up, the CBT response remained significantly better than stress education (the control therapy), while yoga was no longer significantly better, suggesting CBT may have more robust, longer-lasting anxiety-reducing effects. The results were published online August 12 in JAMA Psychiatry.

The study involved an evidence-based protocol for CBT treatment of generalized anxiety disorder, including psychoeducation, cognitive interventions (focused on identifying and adapting maladaptive thoughts and worrying), and muscle relaxation techniques.

Kundalini yoga included physical postures, breathing techniques, relaxation exercises, yoga theory, and meditation and mindfulness practice.

The stress management education control group received lectures about the physiological, psychological, and medical effects of stress, as well as the antianxiety effects of lifestyle behaviors, such as reducing alcohol and smoking, and the importance of exercise and a healthy diet. Homework consisted of listening to educational material about stress, nutrition, and lifestyle.

Each treatment was administered in groups of 3 to 6 participants, over weekly 2-hour sessions for 12 weeks with 20 minutes of daily homework assigned.

According to researchers, generalized anxiety disorder is a common, impairing, and undertreated condition, currently affecting an estimated 6.8 million Americans. While most people feel anxious from time to time, it is considered a disorder when worrying becomes excessive and interferes with day-to-day life. CBT is considered the gold standard first-line treatment. Medications, including antidepressants and sometimes benzodiazepines, may also be used. Yet, not everyone is willing to take medication, which can have adverse side effects, and there are challenges with accessing CBT for many, including lack of access to trained therapists and long waitlists.

Many people already seek complementary and alternative interventions, including yoga, to treat anxiety, says Dr. Simon. This study suggests that at least short-term there is significant value for people with generalized anxiety disorder to give yoga a try to see if it works for them. Yoga is well-tolerated, easily accessible, and has a number of health benefits.

According to Dr. Simon, future research should aim to understand who is most likely to benefit from yoga for generalized anxiety disorder to help providers better personalize treatment recommendations.

We need more options to treat anxiety because different people will respond to different interventions, and having more options can help overcome barriers to care, she says. Having a range of effective treatments can increase the likelihood people with anxiety will be willing to engage in evidence-based care.

Along with Dr. Simon, other authors of this study are Stefan G. Hofmann of Boston University; David Rosenfield at Southern Methodist University in Dallas; Susanne S. Hoeppner and Eric Bui of Massachusetts General Hospital, Harvard Medical School in Boston; Elizabeth A. Hoge of Georgetown University Medical Center in Washington, D.C.; and Sat Bir S. Khalsa of Brigham and Womens Hospital, Harvard Medical School in Boston.

Funding for the work came from the National Center for Complementary and Integrative Health grants R01 AT007258 and R01 AT007257 to Dr. Simon and Dr. Hofmann.

Ashley WelchPhone: 212-404-3511ashley.welch@nyulangone.org

Read more:
Yoga Shown to Improve Anxiety, Study Finds | NYU Langone News - NYU Langone Health

Global Health Coaching Market Potential Growth, Share, Demand and Analysis of Key Players- Research Forecasts to 2025 – Express Journal

According to latest research report on Global Health Coaching Market report provides information related to market size, production, CAGR, gross margin, growth rate, emerging trends, price, and other important factors. Focusing on the key momentum and restraining factors in this market, the report also provides a complete study of future trends and developments in the market.

The Health Coaching report contains all the details of the expected market dynamics and new market opportunities due to the COVID-19 outbreak. Stratagem Market Insights tried to cover all the market analysis of annual economic growth in the latest report on the Health Coaching market.

According to analysts, the growth of the Health Coaching market will have a positive impact on the global platform and will witness gradual growth over the next few years. This report study incorporates all the market growth and restraining factors along with the important trends mentioned between 2020 and 2025.

Request Sample Copy of this Report @ https://www.express-journal.com/request-sample/168077

Market segmentation:

The Health Coaching market has been segmented into a variety of essential industries including applications, types, and regions. In the report, each market segment is studied extensively, taking into account market acceptance, value, demand, and growth prospects. Segmentation analysis allows customers to customize their marketing approach to make better orders for each segment and identify the most potential customers.

Global Health Coaching Market Segmentation by Application:

Global Health Coaching Market Segmentation by Product:

Competitive Landscape

This section of the report identifies various major manufacturers in the market. It helps readers understand the strategies and collaborations players are focusing on fighting competition in the marketplace. The comprehensive report gives a microscopic view of the market. The reader can identify the manufacturers footprint by knowing about the manufacturers global revenue, the manufacturers global price, and the manufacturers production during the forecast period.

The major manufacturers covered in this report:

Regional Insights of Health Coaching Market:

In terms of geography, this research report covers almost all major regions around the world such as North America, Europe, South America, Middle East, Africa, and the Asia Pacific. Europe and North America are expected to increase over the next few years. Health Coaching markets in the Asia-Pacific region are expected to experience significant growth during the forecast period. Advanced technology and innovation are the most important characteristics of North America and the main reason why the United States dominates the world market. The Health Coaching market in South America is also expected to expand in the near future.

Years considered for this report:

Important Facts about Health Coaching Market Report:

Questions Answered by the Report:

Request Customization on This Report @ https://www.express-journal.com/request-for-customization/168077

Excerpt from:
Global Health Coaching Market Potential Growth, Share, Demand and Analysis of Key Players- Research Forecasts to 2025 - Express Journal

From exploring immigrant identities to treating cancer: U of T awarded 29 Canada Research Chairs – News@UofT

The University of Torontos Neda Maghbouleh seeks to better understand how borders, wars and other geopolitical forces influence the formation of immigrants identities.

My work is fundamentally motivated by unresolved questions about integration, assimilation, and racialization, says Maghbouleh, an associate professor in U of T Mississaugas department of sociology.

Through a strategic focus on Syrian refugees and others from the Middle Eastern/North African region, I am building a multilevel analysis of the evolving identities of newcomers to Canada and the U.S. today.

The goal is to advance new theories that explain the influence of geopolitics, borders, war, sanctions and surveillance on everyday peoples racial identifications and attachments.

An international expert on the formation of racial identity, Maghbouleh is one of 29 new or renewed Canada Research Chairs at U of T. Her tier two chair in migration, race and identity will allow her to further expand her scholarship on how racial identities traffic across borders and categories.

The Canada Research Chair Program was established in 2000 to fund outstanding researchers in this country. It provides approximately $295 million annually to universities to help retain and attract top minds, spur innovation and foster training excellence in Canadian post-secondary institutions.

Congratulations to the University of Torontos new and renewed Canada Research Chairs, says University Professor Ted Sargent, U of Ts vice-president, research and innovation, and strategic initiatives. This investment will further strengthen and build on the exceptional research environment at U of T.

The Canada Research Chairs Program enables our nations researchers to make ground-breaking discoveries, create new knowledge and attract talent that ultimately benefits all Canadians.

Maghbouleh is among those emerging researchers who are making their mark. Her 2017 award-winning book The Limits of Whiteness: Iranian Americans and the Everyday Politics of Race explored the culture and identity of Iranian Americans as well as the discrimination they face. It has been adopted in courses at over 30 universities in North America and the U.K.

Since she became a faculty member at U of T Mississauga in 2015, Maghboulehs research has received consistent funding from the Social Sciences and Humanities Research Council of Canada (SSHRC), including a major Insight Grant for the project Settlement, Integration, & Stress: A 5-Year Longitudinal Study of Syrian Newcomer Mothers & Teens in the GTA. She recently presented early findings from the project to the research and evaluation branch of Immigration, Refugees and Citizenship Canada.

Maghbouleh says the research chair will help fuel her ambitious research program and further communicate her findings.

The CRC will turbo-charge my work, she says. And most excitingly, it solidifies the status of UTM, U of T and the Greater Toronto Area as a premier North American hub for research on migration and race.

Kent Moore, U of T Mississaugas vice-principal, research, said he was thrilled with the campuss success in securing three Canada Research Chair designations. In addition to Maghbouleh, they include Sonia Kang in the department of management, who is a newly named tier two chair in identity, diversity, and inclusion, and Iva Zovkic in the department of psychology, who is a tier two chair in behavioural epigenetics.

This recognition exemplifies the innovative work being undertaken by our researchers, says Moore.

With the impressive and exceptional breadth of work Professors Kang, Maghbouleh and Zovkic are doing, they continue to forge new ground in many areas of research and elevate UTM to a higher level of excellence. This support and validation of their work by the Canada Research Chair program demonstrates the outstanding caliber of their scholarly leadership.

Here are the new and renewed Canada Research Chairs at U of T:

New Canada Research Chairs

Renewals of Canada Research Chairs

Go here to see the original:
From exploring immigrant identities to treating cancer: U of T awarded 29 Canada Research Chairs - News@UofT

Dear Dietitian Are there dietary supplements that help with arthritis? – Kiowa County Press

Dear Readers:

When it comes to physical activities, have you concluded that you're not as young as you used to be? Maybe you were once a runner, and now the knees don't bend like they used to. Or perhaps you were a star athlete in high school, and now your star just isn't as bright. The body has gotten older, the joints stiffer, maybe it's even affecting your everyday life. It's a foe that sometimes rears its ugly head in mid-life; it's arthritis.

In the US, as many as 54 million people suffer from osteoarthritis (OA). The word comes from the Greek "osteon" meaning bone, and "itis" meaning inflammation. OA is the most common form of arthritis and occurs when the cartilage that cushions bones wears down over time. Joints can become painful, swollen, and difficult to move. The most commonly affected areas are knees, hands, hips, lower back, and neck.

Some supplements claim to ease arthritis pain, but do they work? Glucosamine, chondroitin, and curcumin (found in turmeric) are three dietary supplements we will explore. Glucosamine and chondroitin, often sold in combination, are two of the top-selling natural remedies for OA. In a meta-analysis of randomized controlled trials (the gold standard for research), Zhu et al. found that glucosamine was more effective than a sugar pill in alleviating joint stiffness. At the same time, chondroitin was better at improving pain and mobility. The analysis did not find enough studies to draw a conclusion about the combination therapy of the two (1).

In the 2019 treatment guidelines, the Arthritis Foundation and American College of Rheumatology gave a conditional recommendation of chondroitin sulfate for hand OA. However, the National Center for Complementary and Integrative Health says the evidence on glucosamine for OA is unclear, and chondroitin isn't helpful. Still, these supplements have not found to be harmful (2).

Another popular remedy for OA is curcumin, the ingredient in turmeric that has anti-inflammatory effects. In another meta-analysis Daily et al. concluded that curcumin, in addition to conventional medicine, may be useful in treating arthritis symptoms (3). In another study, curcumin was found to be as effective in treating arthritis of the knee as the drug diclofenac. However, this study was small and only lasted one month (4).

When it comes to your health, be an informed consumer. A little homework may be necessary before purchasing a supplement for arthritis symptoms. The following websites will help you make a sound decision:

Consult your doctor before beginning any dietary supplement.

Until next time, be healthy!

Dear Dietitian

References

https://www.health.harvard.edu/blog/curcumin-for-arthritis-does-it-really-work-2019111218290

See original here:
Dear Dietitian Are there dietary supplements that help with arthritis? - Kiowa County Press

What is necessary to assure school safety amid COVID-19? – Los Angeles Times

Across America, the back-to-school season is nearly upon us. Yet for millions of children, that wont necessarily mean returning to their classrooms.

School administrators, public health officials and epidemiologists are still working to understand what it will take to make school campuses safe in the midst of the COVID-19 pandemic.

The health and safety of all in the school community is not something we can compromise on, said L.A. schools Supt. Austin Beutner, head of the second-largest district in the country. Our goal is to have students back in schools as soon as it is safe and appropriate to do so.

But what exactly does safe and appropriate mean?

The answer depends on the priorities, resources and risk tolerance in a particular community.

Newsletter

Get our free Coronavirus Today newsletter

Sign up for the latest news, best stories and what they mean for you, plus answers to your questions.

Enter Email Address

Sign Me Up

You may occasionally receive promotional content from the Los Angeles Times.

Quite frankly, the context of COVID-19 transmission and spread is so different across communities that a one-size-fits-all solution is not appropriate, said Kenne Dibner, an education researcher at the National Academies of Sciences, Engineering, and Medicine who served as the staff director for a report on reopening schools that has been downloaded more than 300,000 times.

Dibner and other experts spoke to The Times about how to think through the complex, controversial and multi-pronged problem of reopening.

COVID-19 statistics are everywhere. All you need is a smartphone to see the number of people who have tested positive for the coronavirus, how fast it is spreading, how many ventilators are available in hospitals near you, and whether the number of deaths reported each day is rising or falling.

Despite the abundance of data, there is no magic number that automatically means its safe for schools to reopen.

We cannot offer zero risk, said Dr. Neha Nanda, the medical director of infection prevention at Keck Medicine of USC. The best we can do is combine a concoction of imperfect measures to come up with an optimal strategy.

For example, decision makers at L.A. Unified School District will pay special attention to the number of new cases per day and the proportion of coronavirus tests that come back positive as the two leading indicators of when we can consider bringing students back, Beutner said.

California guidelines require that a countys test positivity rate be no higher than 8% for two consecutive weeks in order for schools there to even consider reopening. As of Wednesday, the seven-day average positivity rate in L.A. County was 8.3%.

Beutner noted that the World Health Organization recommends keeping schools closed until the positive rate drops to 5%.

Having two weeks of less than 5% positivity seems a little difficult to achieve any time soon, unless we learn something more about the virus between then and now, Nanda said.

To help educators think through the health risks, Lauren Ancel Meyers, a professor of integrative biology at the University of Texas at Austin, created a tool that estimates how many kids and teachers would be likely to bring the coronavirus with them to campus if schools in their county were to reopen. Those estimates are based on the prevalence of the virus in the area and the size of the school, among other factors.

The tool is imperfect, since theres still so much uncertainty about how likely it is that a single student or teacher with the virus would infect others in the school. Researchers suspect that age makes a difference, though theyre not sure how much. Preventive measures in place at a school, such as the ability to social distance and adequate ventilation, matter too.

I am by no means for keeping schools closed, Ancel Meyers said. The point of doing these calculations is to provide information that can help deciders make the best decisions

Most of the debate is focused on the health risks of opening schools, but childrens health can suffer when schools are closed as well. Thats something decision-makers should keep in mind, according to a recent editorial published in the Journal of the American Medical Assn.

Weighing these competing health risks is a challenge, however. Compared with other types of data, the health risks associated with keeping schools closed are typically more diffuse, accrue over longer periods of time, and are more difficult to measure.

But that doesnt mean they dont exist.

Einstein said Not everything that counts can be counted, said Julie Donohue, a professor of health policy and management at the University of Pittsburgh and co-author of the JAMA editorial. We are massively experiencing that quote right now.

Schools provide an array of benefits to children and families in addition to education meals, physical and mental health services, support for students with learning difficulties and other special needs, and essential childcare that allows parents to work. Take these away and student health could suffer, Donohue said.

We need to ask ourselves, are we trying to maximize health outcomes, or are we trying to maximize COVID health outcomes, she said.

COVID-19 has not affected everyone equally, and school closures wont either.

Students from families with more advantages including parents who can work from home and access to high-speed internet connections will likely fare better with remote learning. Meanwhile, students who rely on school for meals and health services will be giving up more when school buildings are closed.

In addition, younger students, particularly those learning to read, are expected to get less out of virtual school than older children.

Teachers, administrators, public health workers, physicians, social workers and others should all be invited to offer their thoughts on whether to reopen schools. But the families who will feel the greatest impact of school closures must be at the decision-making table too, experts said.

The risk associated with coming back to schools really varies from family to family, and so we need to hear peoples real authentic experience, said Keisha Scarlett, chief of equity, partnerships and engagements for Seattle Public Schools and a contributor to the National Academies report.

Thats why Scarlett and her co-authors recommend that the decision of when and how to reopen schools be made by a broad coalition that can assess the resources a community has to support students staying at home, or safely returning to school.

Different communities rely on schools in different ways, and that needs to be considered in the process, said Dibner, director of the report.

It often feels as though weve been dealing with the coronavirus forever, but its been less than a year since it first infected humans, and scientists still have a lot to learn.

For instance, children under 18 make up just 5% of reported cases, which may be a sign that theyre more likely to carry the virus without developing symptoms. However, it is unclear how effective kids are at transmitting the virus, especially in a school setting.

Some countries in Europe have been able to reopen schools without seeing massive increases in case numbers. But when Israel reopened, cases spiked.

Learning from others, and learning from other countries, may be the best we can do right now, Nanda said. We have to be very conscientious about what is happening across the world and have an open mind.

We can also expect that circumstances here will change. Imagine the arrival of a COVID-19 test that worked like a pregnancy test, which would enable students and teachers to painlessly test themselves weekly or even daily.

Or perhaps a new treatment will be found that would make the virus less deadly. That would be a game-changer, Ancel Meyers said.

I wouldnt be respecting the virus if I said there wasnt more to learn, Nanda said. This thing has taught us humility very well.

Continue reading here:
What is necessary to assure school safety amid COVID-19? - Los Angeles Times

Women in masks, men in denial: Why some say they wont cover up to fight COVID-19 – NJ.com

Cheryl Schneider was leaving the checkout counter at her local Target Wednesday when she saw them.

Two men, just a few feet away from her, their faces completely exposed.

How about wearing your mask? said Schneider, 66. Its required.

I am, one of the men said, smiling and pointing at his chin. His face covering hung like a silly beard, protecting no one.

Idiot! said Schneiders daughter, Gabrielle, 33.

It wasnt the New Yorkers first such exchange. She likes using the catchphrase mask it or casket when she sees people ignoring the rules.

Ive been cursed at, yelled at, called names, says Schneider, a public relations professional. But I dont care.

Most of the people she sees without a mask?

Men.

Even as masks have become a part of our daily pandemic uniform and are required in all indoor and non-socially distanced outdoor spaces in New Jersey recent surveys show men are less likely to say they wear them all the time, and more likely to say they dont wear them at all.

A Gallup survey of 3,615 adults age 18 and older conducted June 29 to July 5 found that 20% of men said they never wear a mask outside the home, compared with 8% of women. Men were also less likely to say they intend to wear face coverings in a spring survey of 2,459 people in the United States from the Mathematical Sciences Research Institute in Berkeley, California and Middlesex University in London.

Men more than women believe that they will be relatively unaffected by the disease, researchers said in their May report. This is particularly ironic because official statistics show that actually the coronavirus (COVID-19) impacts men more seriously than women.

People lining up to buy beach badges in Belmar in May. Outdoor scenes aren't always so mask-compliant and not every state mandates that masks be worn indoors. Patti Sapone | NJ Advance Media for NJ.com

Why would men behave as if being a man equates to some kind of coronavirus immunity?

Its called maskulinity with a K, says Yasemin Besen-Cassino, a sociologist at Montclair State University.

That is a part of masculine identity and how we raise men, she says. Admitting this is something that can threaten your health is in direct conflict with how we assign masculinity.

This is also why men are less likely to get regular check-ups at the doctor and more likely to engage in risky behavior, Besen-Cassino says.

People men included have used masks to express their personal sense of style, team allegiances and New Jersey pride (Gov. Phil Murphy wore one that advertised his Parkway exit, 109). But in the May survey, men were more likely than women to agree that masks are shameful, not cool, a sign of weakness and a stigma, researchers said.

Of course, that assumes masks are intended to protect the wearer. On the contrary, we mainly wear them to shield others from getting COVID-19 from us, whether or not we have contracted the virus or know we have it.

Various stages of mask-wearing (and the absence of masks) on display at the pedestrian plaza on Jersey City's Newark Avenue in July. Aristide Economopoulos | NJ Advance Media for NJ.com

We raise women to be more caring and more susceptive to their environment, Besen-Cassino says. Wearing a mask is caring about other people and making sure others are okay.

The COVID-19 Consortium for Understanding the Publics Policy Preferences Across States surveyed 19,058 people across the country from July 10 to 26. The survey showed that 77% of women said they had followed the recommendation to wear a mask outside the home very closely, compared with 69% of men, says Katya Ognyanova, a professor of communication at Rutgers University in New Brunswick. The consortium is a joint project of Rutgers, Harvard, Northeastern and Northwestern universities.

In public health we work really hard to work on behavior change, says Rosie Frasso, director of public health at Thomas Jefferson University in Philadelphia, which operates medical centers in South Jersey. We try and understand the role of gender ... weve really screwed up with the messaging around this as a country.

For some, being outside has become a signal that masks are not necessary.Aristide Economopoulos | NJ Advance Media for NJ.com

An early aversion to masks was on full display with government leaders, including President Donald Trump and Vice President Mike Pence, chair of the White House Coronavirus Task Force. But even off TV screens, Frasso has anecdotally noticed gender differences in mask wearing.

The data on COVID show that men with COVID do far worse than women, she says. They should be extra motivated to avoid it.

Women are more likely to embrace masks because of an approach Frasso likens to putting on an oxygen mask before helping others on a plane.

Women are in lots of ways more responsible about health and health behavior than men because they end up being the organizers of health care for families, she says.

Its a pattern weve seen before.

Women adopted seatbelt use more readily than men, and that was a very similar debate, Frasso says.

For the most part, New Jersey's mask mandate can take the gendered "choice" out of mask wearing. Pictured: Cranford in July.Aristide Economopoulos | NJ Advance Media

Women readily see the connections between community and self, says Noah Kass, a psychotherapist and clinical director for NY Health Hypnosis and Integrative Therapy in Manhattan.

Men are more in touch with their ego they almost put themselves outside of their community and see that as a source of pride ... certainly the president doesnt help.

Men are more likely to be in denial about health problems, says Melinda Hall, director of the gender studies program at Stetson University in DeLand, Florida. But that kind of denial can also be seen in American culture at large, which upholds the myth that to be human is to work constantly and somehow not get sick. The health crisis, by keeping many at home, has often triggered a reassessment of round-the-clock productivity.

Autonomy and independence are really more of a fiction than anything, Hall says of the rugged individualist identity associated with America. Women are doing the kinds of work that highlights our interdependence.

Women wearing masks at the Haskell Invitational at Monmouth Park in July. It is women who often manage health care for their entire family.Andrew Mills | NJ Advance Media for NJ.com

How can officials cut down on gender-based mask avoidance? One solution can be found in measures that are already in effect in New Jersey and across the country. The May survey on mask use found that the disparity between women and men when it came to intentions about wearing face coverings almost disappears in places where they are mandatory.

A statewide New Jersey mask mandate applying to outdoor spaces went into effect July 8, expanding on the earlier mandate for indoor spaces. Though its clear that not everyone is wearing a mask outside when they arent social distancing, the COVID-19 Consortium survey found that 82% of New Jerseyans surveyed (of a total 388) said they followed mask recommendations very closely.

By comparison, of 254 people surveyed in South Dakota, which has no statewide mask mandate, just 37% said they did the same, and 21% said they followed guidelines to wear face coverings not at all closely.

The Gallup survey found that women (54%), Northeasterners (54%), people 55 and up (47%) and those with annual household incomes under $36,000 (51%) were among the top groups to say they always wear masks outside the home.

President Donald Trump wears a mask July 27 while touring a lab that makes components for a potential COVID-19 vaccine in Morrisville, North Carolina. For months after the CDC recommended them, Trump did not wear a mask.Jim Watson | AFP via Getty Images

But mask analysis isnt limited to gender, age, location and income. The COVID-19 Consortium found Asian respondents (85%) were most likely to say they wore a mask outside the home, echoing the example of mask-wearing cultures found in Asian countries. African American respondents (81%) followed, along with Hispanic respondents (80%). White mask wearers came in at 70%.

Looking at political affiliation, Democrats (84%) were most likely to say they closely follow guidelines to wear masks, while Republicans were least likely (64%). Democrats (92%) were also most likely to say masks are effective in preventing COVID-19 infection, and Republicans were least likely (76%).

President Trump, the most visible Republican, did not wear face coverings at public events for months after the Centers for Disease Control and Prevention recommended masks, and retweeted messages implying that former Vice President Joe Biden looked weak by wearing them. Trump also told told a reporter wearing a mask that he must want to be politically correct.

The president has since reversed course, wearing a mask in public for the first time in July at Walter Reed National Military Medical Center. He later tweeted a photo of himself in his presidential face covering, saying that wearing masks is considered patriotic.

People wore gauze masks during the 1918 flu pandemic, when putting one on was equated to supporting the war effort. National Archives and Records Administration/public domain

Trump deciding to wear a mask several months into the pandemic is like showing up to a baby shower with condoms, says Dr. Niket Sonpal, professor of clinical medicine at Touro College of Osteopathic Medicine in New York. Its too late.

The politicization of masks can transcend gender differences, as seen in Karen videos that depict middle-aged white women vehemently refusing to wear the face coverings. In June, when staff at a California Trader Joes confronted a woman for not wearing a mask, she proceeded to thrown down her cart and yell Democratic pigs! at people in the store. In July, a woman in Arizona filmed herself dismantling an entire mask display in Target because she disapproved. These anti-mask actors often claim that it is their right to flout store policies or state mandates by going without a mask.

A century ago, masks were routinely associated with patriotism and heroism. In the 1918 flu pandemic, putting on gauze masks to guard against infection was likened to soldiers overseas wearing gas masks during World War I, says Katie Foss, professor of media studies at Middle Tennessee State University.

If we think about the Spanish Flu, most of the messages we got about disease at that time were underscored by war discourse, says Foss, author of the forthcoming book Constructing the Outbreak: Media in Epidemics and Collective Memory (September, University of Massachusetts Press).

We have this switch from wearing a mask is a masculine thing, we moved away from that, Foss says, calling todays mask a loaded symbol.

In one survey, men were more likely to associate masks with weakness.Aristide Economopoulos | NJ Advance Media for NJ.com

While hand-washing may be second nature, those gauze masks from 1918 do not live in the public memory of 2020.

That fact that we dont have a cultural norm around mask-wearing makes this much more difficult, says Leslie Kantor, chair of the department of urban-global public health at Rutgers in Newark.

Still, that doesnt mean popular thinking about masks cant be reprogrammed.

We have a fast-moving epidemic and peoples personal habits are slow to change, Kantor says. We can change the associations with these prevention objects. We never stopped telling people how to prevent HIV and STDs and pregnancy you have to keep going.

Thank you for relying on us to provide the journalism you can trust. Please consider supporting NJ.com with a voluntary subscription.

Amy Kuperinsky may be reached at akuperinsky@njadvancemedia.com. Send a coronavirus tip here.

See the article here:
Women in masks, men in denial: Why some say they wont cover up to fight COVID-19 - NJ.com

FREE WEBINAR | Join the Mims Medical Lounge on how to protect your family from Covid-19 – TimesLIVE

Our panel of medical and health experts will give you practical pointers on Covid-19 prevention such as:

Join the Mims Medical Lounge brought to you by TimesLIVE, as our panel of experts discuss how to protect your family from Covid-19.

The panel of experts include:

Dr Martin de Villiers (doctor of family medicine, university lecturer and medical director of Medwell SA, which specialises in home-based care)Dr Zimbini Ogle (clinical psychologist leading Impilo yeAfrica. With an MA in Clinical Psychology and PhD in Psychiatry, Dr Ogle treats common mental disorders, depression and anxiety disorders)Dr Maria Christodoulou (medical practitioner and an expert in integrative medicine. Dr Christodoulou specialises in coaching individuals to reclaim their health, align with their purpose, and liberate their full potential)Annelie Smith (registered dietitian with extensive experience in private practice and a specialty in nutrigenomics and functional nutrition. Smith heads up mentorship for 3X4 Genetics)Jani Greeff (creative consultant, songwriter, director and playwright. Greeff is a mother to a toddler and wife of musician husband Pierre of Die Heuwels Fantasties)

Date: Tuesday, August 11 2020Time: 4pm

See the rest here:
FREE WEBINAR | Join the Mims Medical Lounge on how to protect your family from Covid-19 - TimesLIVE

Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability – Science Magazine

Sites of vulnerability in SARS-CoV-2

Antibodies that neutralize severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) could be an important tool in treating coronavirus disease 2019 (COVID-19). Brouwer et al. isolated 403 monoclonal antibodies from three convalescent COVID-19 patients. They show that the patients had strong immune responses against the viral spike protein, a complex that binds to receptors on the host cell. A subset of antibodies was able to neutralize the virus. Competition and electron microscopy studies showed that these antibodies target diverse epitopes on the spike, with the two most potent targeting the domain that binds the host receptor.

Science, this issue p. 643

The rapid spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has had a large impact on global health, travel, and economy. Therefore, preventative and therapeutic measures are urgently needed. Here, we isolated monoclonal antibodies from three convalescent coronavirus disease 2019 (COVID-19) patients using a SARS-CoV-2 stabilized prefusion spike protein. These antibodies had low levels of somatic hypermutation and showed a strong enrichment in VH1-69, VH3-30-3, and VH1-24 gene usage. A subset of the antibodies was able to potently inhibit authentic SARS-CoV-2 infection at a concentration as low as 0.007 micrograms per milliliter. Competition and electron microscopy studies illustrate that the SARS-CoV-2 spike protein contains multiple distinct antigenic sites, including several receptor-binding domain (RBD) epitopes as well as non-RBD epitopes. In addition to providing guidance for vaccine design, the antibodies described here are promising candidates for COVID-19 treatment and prevention.

The rapid emergence of three novel pathogenic human coronaviruses in the past two decades has caused major concerns. The latest, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is responsible for >3 million infections and 230,000 deaths worldwide as of 1 May 2020 (1). Coronavirus disease 2019 (COVID-19), caused by SARS-CoV-2, is characterized by mild, flu-like symptoms in most patients. However, severe cases can present with bilateral pneumonia that may rapidly deteriorate into acute respiratory distress syndrome (2). With high transmission rates and no proven curative treatment available, health care systems are severely overwhelmed, and stringent public health measures are in place to prevent infection. Safe and effective treatment and prevention measures for COVID-19 are urgently needed.

During the outbreak of the first severe acute respiratory syndrome coronavirus (SARS-CoV) and Middle Eastern respiratory syndrome coronavirus (MERS-CoV), plasma of recovered patients containing neutralizing antibodies (NAbs) was used as a safe and effective treatment option to decrease viral load and to reduce mortality in severe cases (3, 4). Recently, a small number of COVID-19 patients treated with convalescent plasma showed clinical improvement and a decrease in viral load (5). An alternative treatment strategy would be to administer purified monoclonal antibodies (mAbs) with neutralizing capacity. mAbs can be thoroughly characterized in vitro and expressed in large quantities. In addition, because of the ability to control dosing and composition, mAb therapy has improved efficacy over convalescent plasma treatment and prevents the potential risks of antibody-dependent enhancement (ADE) from non-neutralizing or poorly neutralizing Abs present in plasma that consists of a polyclonal mixture (6). Recent studies with patients infected with the Ebola virus highlight the superiority of mAb treatment over convalescent plasma treatment (7, 8). Moreover, mAb therapy has been proven safe and effective against influenza virus, rabies virus, and respiratory syncytial virus (RSV) (911).

The main target for NAbs on coronaviruses is the spike (S) protein, a homotrimeric glycoprotein that is anchored in the viral membrane. Recent studies have shown that the S protein of SARS-CoV-2 bears considerable structural homology to that of SARS-CoV, consisting of two subdomains: the N-terminal S1 domain, which contains the N-terminal domain (NTD) and the RBD for the host cell receptor angiotensin-converting enzyme-2 (ACE2), and the S2 domain, which contains the fusion peptide (12, 13). Similar to other viruses containing class 1 fusion proteins (e.g., HIV-1, RSV, and Lassa virus), the S protein undergoes a conformational change and proteolytic cleavage upon host cell receptor binding from a prefusion to a postfusion state, enabling merging of viral and target cell membranes (14, 15). When expressed as recombinant soluble proteins, class 1 fusion proteins generally have the propensity to switch to a postfusion state. However, most NAb epitopes present in the prefusion conformation (1618). The recent successes of isolating potent NAbs against HIV-1 and RSV using stabilized prefusion glycoproteins reflect the importance of using the prefusion conformation for isolating and mapping mAbs against SARS-CoV-2 (19, 20).

Early efforts at obtaining NAbs focused on reevaluating SARS-CoVspecific mAbs isolated after the 2003 outbreak that might cross-neutralize SARS-CoV-2 (21, 22). Although two mAbs were described to cross-neutralize SARS-CoV-2, most SARS-CoV NAbs did not bind SARS-CoV-2 S protein or neutralize SARS-CoV-2 virus (12, 2123). More recently, the focus has shifted from cross-neutralizing SARS-CoV NAbs to the isolation of new SARS-CoV-2 NAbs from recovered COVID-19 patients (2428). S protein fragments containing the RBD have yielded multiple NAbs that can neutralize SARS-CoV-2 by targeting different RBD epitopes (2428). In light of the rapid emergence of escape mutants in the RBD of SARS-CoV and MERS, monoclonal NAbs targeting epitopes other than the RBD are a valuable component of any therapeutic antibody cocktail (29, 30). Indeed, therapeutic antibody cocktails with a variety of specificities have been used successfully against Ebola virus disease (7) and are being tested widely in clinical trials for HIV-1 (31). NAbs targeting non-RBD epitopes have been identified for SARS-CoV and MERS, supporting the rationale for sorting mAbs using the entire ectodomain of the SARS-CoV-2 S protein (32). In addition, considering the high sequence identity between the S2 subdomains of SARS-CoV-2 and SARS-CoV, using the complete S protein ectodomain instead of only the RBD may allow the isolation of mAbs that cross-neutralize different -coronaviruses (33). In an attempt to obtain mAbs that target both RBD and non-RBD epitopes, we set out to isolate mAbs using the complete prefusion S protein ectodomain of SARS-CoV-2.

We collected a single blood sample from three polymerase chain reactionconfirmed SARS-CoV-2infected individuals (COSCA1, COSCA2, and COSCA3) ~4 weeks after symptom onset. COSCA1 (a 47-year-old male) and COSCA2 (a 44-year-old female) showed symptoms of an upper respiratory tract infection and mild pneumonia, respectively (Table 1). Both remained in home isolation during the course of COVID-19 symptoms. COSCA3, a 69-year-old male, developed a severe pneumonia and became respiratory insufficient 1.5 weeks after symptom onset, requiring admission to the intensive care unit for mechanical ventilation. To identify S proteinspecific antibodies in the sera obtained from all three patients, we generated soluble, prefusion-stabilized S proteins of SARS-CoV-2 using stabilization strategies previously described for S proteins of SARS-CoV-2 and other -coronaviruses (Fig. 1A) (12, 34). As demonstrated by the size-exclusion chromatography trace, SDSpolyacrylamide gel electrophoresis (PAGE), and blue native PAGE, the resulting trimeric SARS-CoV-2 S proteins were of high purity (fig. S1, A and B). Sera from all patients showed strong binding to the S protein of SARS-CoV-2 in an enzyme-linked immunosorbent assay (ELISA), with end-point titers of 13,637, 6133, and 48,120 for COSCA1, COSCA2, and COSCA3, respectively (Fig. 1B), and showed cross-reactivity to the S protein of SARS-CoV (fig. S1C). COSCA1, COSCA2, and COSCA3 had varying neutralizing potencies against SARS-CoV-2 pseudovirus, with 50% inhibition of virus infection (ID50) values of 383, 626, and 7645, respectively (Fig. 1C), and similar activities against authentic virus (fig. S1D). In addition, all sera showed cross-neutralization of SARS-CoV pseudovirus and authentic SARS-CoV virus, albeit with low potency (fig. S1, E and F). The potent S proteinbinding and -neutralizing responses observed for COSCA3 are consistent with earlier findings showing that severe disease is associated with a strong humoral response (35). On the basis of these strong serum binding and neutralization titers, we sorted SARS-CoV-2 S proteinspecific B cells for mAb isolation from COSCA1, COSCA2, and COSCA3.

(A) (Top) Schematic overview of the authentic SARS-CoV-2 S protein with the signal peptide shown in blue and the S1 (red) and S2 (yellow) domains separated by a furin-cleavage site (RRAR; top). (Bottom) Schematic overview of the stabilized prefusion SARS-CoV-2 S ectodomain, where the furin cleavage site is replaced with a glycine linker (GGGG), two proline mutations are introduced (K986P and V987P), and a trimerization domain (cyan) preceded by a linker (GSGG) is attached. (B) Binding of sera from COSCA1, COSCA2, and COSCA3 to prefusion SARS-CoV-2 S protein as determined by ELISA. The mean values and SDs of two technical replicates are shown. (C) Neutralization of SARS-CoV-2 pseudovirus by heat-inactivated sera from COSCA1, COSCA2, and COSCA3. The mean and SEM of at least three technical replicates are shown. The dotted line indicates 50% neutralization.

Peripheral blood mononuclear cells were stained dually with fluorescently labeled prefusion SARS-CoV-2 S proteins and analyzed for the frequency and phenotype of specific B cells by flow cytometry (Fig. 2A and fig S2). The analysis revealed a frequency ranging from 0.68 to 1.74% of S proteinspecific B cells (S-AF647+, S-BV421+) among the total pool of B cells (CD19+Via-CD3CD14CD16), (Fig. 2B). These SARS-CoV-2 S proteinspecific B cells showed a predominant memory (CD20+CD27+) and plasmablasts/plasma cells (PBs/PCs) (CD20CD27+CD38+) phenotype. We observed a threefold higher percentage of PBs/PCs for SARS-CoV-2 S proteinspecific B cells compared with total B cells (P = 0.034), indicating an enrichment of specific B cells in this subpopulation (Fig. 2C). COSCA3, who experienced severe symptoms, showed the highest frequency of PBs/PCs in both total (34%) and specific (60%) B cells (Fig. 2C and fig. S2). As expected, the SARS-CoV-2 S proteinspecific B cells were enriched in the immunoglobulin Gpositive (IgG+) and IgM/IgG (most likely representing IgA+) B cell populations, although a substantial portion of the specific B cells were IgM+, particularly for COSCA3 (Fig. 2D).

(A) Representative gates of SARS-CoV-2 S proteinspecific B cells shown for a nave donor (left panel) or COSCA1 (middle left panel). Each dot represents a B cell. The gating strategy to identify B cells is shown in fig. S2. From the total pool of SARS-CoV-2 S proteinspecific B cells, CD27+CD38 memory B cells (Mem B cells; blue gate) and CD27+CD38+ B cells were identified (middle panel). From the latter gate, PBs/PCs (CD20; red gate) could be identified (middle right panel). SARS-CoV-2 S proteinspecific B cells were also analyzed for their IgG or IgM isotype (right panel). (B) Frequency of SARS-CoV-2 S proteinspecific B cells in total B cells, Mem B cells, and PBs/PCs. Symbols represent individual patients, as shown in (D). (C) Comparison of the frequency of Mem B cells (CD27+CD38) and PB/PC cells (CD27+CD38+CD20) between the specific (SARS-CoV2 S++) and nonspecific B cells (gating strategy is shown in fig. S2). Symbols represent individual patients, as shown in (D). Statistical differences between two groups were determined using paired t test (*P = 0.034). (D) Comparison of the frequency of IgM+, IgG+, and IgMIgG B cells in specific and nonspecific compartments. Bars represent means; symbols represent individual patients.

SARS-CoV-2 S proteinspecific B cells were subsequently single-cell sorted for sequencing and mAb isolation. In total, 409 heavy chain (HC) and light chain (LC) pairs were obtained from the sorted B cells of the three patients (137, 165, and 107 from COSCA1, COSCA2, and COSCA3, respectively), of which 323 were unique clonotypes. Clonal expansion occurred in all three patients (Fig. 3A) but was strongest in COSCA3, where it was dominated by HC variable (VH) regions VH3-7 and VH4-39 (34 and 32% of SARS-CoV-2 S proteinspecific sequences, respectively). Even though substantial clonal expansion occurred in COSCA3, the median somatic hypermutation (SHM) was 1.4%, with similar SHM in COSCA1 and COSCA2 (2.1 and 1.4%, respectively) (Fig. 3B). These SHM levels are similar to those observed in response to infection with other respiratory viruses (36).

(A) Maximum-likelihood phylogenetic tree of 409 isolated paired B cell receptor HCs. Each color represents sequences isolated from different patients (COSCA1, COSCA2, and COSCA3). (B) Violin plot showing SHM levels (%; nucleotides) per patient. The dot represents the median SHM percentage. (C) Distribution of CDRH3 lengths in B cells from COSCA1, COSCA2, and COSCA3 (purple, n = 323) versus a representative nave population from three donors (cyan, n = 9.791.115) (37). (D) Bar graphs showing the mean ( SEM) VH gene usage (%) in COSCA1, COSCA2, and COSCA3 (purple, n = 323) versus a representative nave population (cyan, n = 363,506,788). The error bars represent the variation between different patients (COSCA1, COSCA2, and COSCA3) or nave donors (37). Statistical differences between two groups were determined using unpaired t tests (with HolmSidak correction for multiple comparisons, adjusted P values: *P < 0.05; **P < 0.01; ***P < 0.001).

A hallmark of antibody diversity is the heavy chain complementarity-determining region 3 (CDRH3). Because the CDRH3 is composed of V, D, and J gene segments, it is the most variable region of an antibody in terms of both amino acid composition and length. The average length of CDRH3 in the nave human repertoire is 15 amino acids (37), but for a subset of influenza virus and HIV-1 broadly neutralizing antibodies, long CDRH3 regions of 20 to 35 amino acids are crucial for high-affinity antigenantibody interactions (38, 39). Even though the mean CDRH3 length of isolated SARS-CoV-2 S proteinspecific B cells did not differ substantially from that of a nave population (37), we observed a significant difference in the distribution of CDRH3 length (two-sample KolmogorovSmirnov test, P = 0.006) (Fig. 3C). This difference in CDRH3 distribution can largely be attributed to an enrichment of longer (~20 amino acid) CDRH3s, leading to a bimodal distribution as opposed to the bell-shaped distribution that was observed in the nave repertoire (Fig. 3C and fig. S3).

Next, to determine SARS-CoV-2specific signatures in B cell receptor repertoire usage, we compared ImmunoGenetics (IMGT) databaseassigned unique germline V regions from the sorted SARS-CoV-2 S proteinspecific B cells with the well-defined extensive germline repertoire in the nave population (Fig. 3D) (37). Multiple VH genes were enriched in COSCA1, COSCA2, and COSCA3 compared with the nave repertoire, including VH3-33 (P = 0.009) and VH1-24 (P < 0.001) (Fig. 3D). Even though the enrichment of VH1-69 was not significant (P > 0.05), it should be noted that an enrichment of VH1-69 has been shown in response to a number of other viral infections, including influenza virus, hepatitis C virus, and rotavirus (40), and an enrichment of VH3-33 was observed in response to malaria vaccination, whereas the enrichment of VH1-24 appears to be specific for COVID-19 (Fig. 3D) (41). By contrast, VH4-34 (P > 0.05) and VH3-23 (P = 0.018) were substantially underrepresented in SARS-CoV-2specific sequences compared with the nave population. Although usage of most VH genes was consistent between COVID-19 patients, VH3-30-3 and VH4-39 in particular showed considerable variability. Thus, upon SARS-CoV-2 infection, the S protein recruits a subset of B cells from the nave repertoire enriched in specific VH segments and CDRH3 domains.

Subsequently, all HC and LC pairs were transiently expressed in human embryonic kidney (HEK) 293T cells and screened for binding to SARS-CoV-2 S protein by ELISA. A total of 84 mAbs that showed high-affinity binding were selected for small-scale expression in HEK 293F cells and purified (table S1). We obtained few S proteinreactive mAbs from COSCA3, possibly because most B cells from this individual were IgM+, whereas cloning into an IgG backbone nullified avidity contributions to binding and neutralization present in the serum. To gain insight in the immunodominance of the RBD as well as its ability to cross-react with SARS-CoV, we assessed the binding capacity of these mAbs to the prefusion S proteins and the RBDs of SARS-CoV-2 and SARS-CoV using ELISA. Of the 84 mAbs tested, 32 (38%) bound to the SARS-CoV-2 RBD (Fig. 4, A and B), with seven mAbs (22%) showing cross-binding to SARS-CoV RBD (fig. S4A). We also observed 33 mAbs (39%) that bound strongly to SARS-CoV-2 S but did not bind the RBD, of which 10 mAbs (30%) also bound to the S protein of SARS-CoV (Fig. 4, A and B). Notably, some mAbs that bound very weakly to soluble SARS-CoV-2 S protein in ELISA showed strong binding to membrane-bound S protein, implying that their epitopes are presented poorly on the stabilized soluble S protein or that avidity is important for their binding (table S1). Surface plasmon resonance (SPR) assays confirmed binding of 77 mAbs to S protein and 21 mAbs to the RBD with binding affinities in the nanomolar to picomolar range (table S1).

(A) Bar graph depicting the binding of mAbs from COSCA1 (blue), COSCA2 (red), and COSCA3 (yellow) to SARS-CoV-2 S protein (dark shading) and SARS-CoV-2 RBD (light shading) as determined by ELISA. Each bar indicates the representative area under the curve (AUC) of the mAb indicated below from two experiments. The gray area represents the cutoff for binding (AUC = 1). The maximum concentration of mAb tested was 10 g/ml. (B) Scatter plot depicting the binding of mAbs from COSCA1, COSCA2, and COSCA3 [see (C) for color coding] to SARS-CoV-2 S protein and SARS-CoV-2 RBD as determined by ELISA. Each dot indicates the representative AUC of a mAb from two experiments. (C) Midpoint neutralization concentrations (IC50) of SARS-CoV-2 pseudovirus (left) or authentic SARS-CoV-2 virus (right). Each symbol represents the IC50 of a single mAb. For comparability, the highest concentration was set to 10 g/ml, although the actual start concentration for the authentic virus neutralization assay was 20 g/ml. The IC50s for pseudotyped and authentic SARS-CoV-2 virus of a selection of potently neutralizing RBD and non-RBDspecific mAbs (with asterisk) are shown in the adjacent table. Colored shading indicates the most potent mAbs from COSCA1, COSCA2, and COSCA3.

All 84 mAbs were subsequently tested for their ability to block infection. A total of 19 mAbs (23%) inhibited SARS-CoV-2 pseudovirus infection with varying potencies (Fig. 4C) and, of these, 14 (74%) bound the RBD. Seven of the 19 mAbs could be categorized as potent neutralizers [median inhibitory concentration (IC50) < 0.1 g/ml], six as moderate neutralizers (IC50 = 0.1 to 1 g/mL), and six as weak neutralizers (IC50 = 1 to 10 g/ml). With an IC50 of 0.008 g/ml, the RBD-targeting antibodies COVA1-18 and COVA2-15 in particular were unusually potent. However, they were quite different in other aspects, such as their HC V gene usage (VH3-66 versus VH3-23), LC usage (VL7-46 versus VK2-30), HC sequence identity (77%), and CDRH3 length (12 versus 22 amino acids). Seventeen of the mAbs also interacted with the SARS-CoV S and RBD proteins and two of these cross-neutralized the SARS-CoV pseudovirus (IC50 = 2.5 g/ml for COVA1-16 and 0.61 g/ml for COVA2-02; fig. S4B), with COVA2-02 being more potent against SARS-CoV than against SARS-CoV-2. Next, we assessed the ability of the 19 mAbs to block infection of authentic SARS-CoV-2 virus (Fig. 4C and fig. S4C). Although previous reports suggested a decrease in neutralization sensitivity of primary SARS-CoV-2 compared with pseudovirus (25, 27, 28), we observed very similar potencies for seven of the 19 NAbs, including the most potent NAbs (IC50 = 0.007 and 0.009 g/ml for COVA1-18 and COVA2-15, respectively; Fig. 4C). NAbs COVA1-18, COVA2-04, COVA2-07, COVA2-15, and COVA2-39 also showed strong competition with ACE2 binding, illustrating that blocking ACE2 binding is their likely mechanism of neutralization (fig. S4D). The RBD-targeting mAb COVA2-17, however, showed incomplete competition with ACE2. This corroborates previous observations that the RBD encompasses multiple distinct antigenic sites, some of which do not involve blocking of ACE2 binding (23, 25, 26). The non-RBD NAbs all bear substantially longer CDRH3s compared with RBD NAbs (fig. S4E), suggesting a convergent, CDRH3-dependent contact between antibody and epitope.

To identify and characterize the antigenic sites on the S protein and their interrelationships, we performed SPR-based cross-competition assays using S protein, followed by clustering analysis. We note that competition clusters do not necessarily equal epitope clusters but the analysis can provide clues as to the relationship between mAb epitopes. We identified 11 competition clusters, of which nine contained more than one mAb and two contained only one mAb (clusters X and XI; Fig. 5A and fig. S5). All nine multiple-mAb clusters included mAbs from at least two of the three patients, emphasizing that these clusters represent common epitopes targeted by the human humoral immune response during SARS-CoV-2 infection. Three clusters included predominantly RBD-binding mAbs (clusters I, III, and VII), with cluster I forming two subclusters. These three clusters were confirmed by performing cross-competition experiments with soluble RBD instead of complete S protein (fig. S5B). Four clusters (V, VI, XIII, and IX) included predominantly mAbs that did not interact with RBD, and clusters II, IV, X, and XI consisted exclusively of non-RBD mAbs. mAbs with diverse phenotypes (e.g., RBD and non-RBDbinding mAbs) merged together in multiple clusters, suggesting that these mAbs might target epitopes bridging the RBD and non-RBD sites or that they sterically interfere with each others binding as opposed to binding to overlapping epitopes. Although clusters II, V, and VIII contained only mAbs incapable of neutralizing SARS-CoV-2, clusters I, III, IV, VI, and VII included both non-NAbs and NAbs. Cluster V was formed mostly by non-RBDtargeting mAbs that also bound to SARS-CoV. However, these mAbs were not able to neutralize either SARS-CoV-2 or SARS-CoV, suggesting that these mAbs target a conserved non-neutralizing epitope on the S protein. Finally, the two non-RBD mAbs COVA1-03 and COVA1-21 formed single-mAb competition clusters (clusters X and XI, respectively) and showed an unusual competition pattern, because binding of either mAb blocked binding by most of the other mAbs, but not vice versa (figs. S5 and S6 and table S2). We hypothesize that these two mAbs allosterically interfere with mAb binding by causing conformational changes in the S protein that shield or impair most other mAb epitopes. COVA1-21 also efficiently blocked virus infection without blocking ACE2, suggesting an alternative mechanism of neutralization than blocking ACE2 engagement (fig. S4C). The SPR-based clustering was corroborated using biolayer interferometry competition assays on a subset of NAbs (fig. S6). Overall, our data are consistent with the previous identification of multiple antigenic RBD sites for SARS-CoV-2 and additional non-RBD sites on the S protein, as described for SARS-CoV and MERS-CoV (32, 42).

(A) Dendrogram showing hierarchical clustering of the SPR-based cross-competition heat map (table S2). Clusters are numbered I to XI and are depicted with color shading. ELISA binding to SARS-CoV-2 S protein, SARS-CoV S protein, and SARS-CoV-2 RBD as presented by AUC and neutralization IC50 (g/ml) of SARS-CoV-2 is shown in the columns on the left. ELISA AUCs are shown in gray (AUC < 1) or blue (AUC > 1), and neutralization IC50 is shown in gray (>10 g/ml), blue (1 to 10 g/ml), violet (0.1 to 1 g/ml), or purple (0.001 to 0.1 g/ml). Asterisks indicate antibodies that cross-neutralize SARS-CoV pseudovirus. (B) Composite figure demonstrating binding of NTD-mAb COVA1-22 (blue) and RBD mAbs COVA2-07 (green), COVA2-39 (orange), COVA1-12 (yellow), COVA2-15 (salmon), and COVA2-04 (purple) to SARS-CoV-2 spike (gray). The spike model (PDB 6VYB) is fit into the density. (C) Magnification of SARS-CoV-2 spike comparing epitopes of RBD mAbs with the ACE2-binding site (red) and the epitope of mAb CR3022 (blue). (D) Side (left) and top (right) views of the 3D reconstruction of COVA2-15 bound to SARS-CoV-2 S protein. COVA2-15 binds to both the down (magenta) and up (salmon) conformations of the RBD. The RBDs are colored blue in the down conformation and black in the up conformation. The angle of approach for COVA2-15 enables this broader recognition of the RBD while also partially overlapping with the ACE2-binding site and therefore blocking receptor engagement.

To visualize how selected NAbs bound to their respective epitopes, we generated FabSARS-CoV-2 S complexes that were imaged by single-particle negative-stain electron microscopy (EM; Fig. 5, B and C, and fig. S7). We obtained low-resolution reconstruction with six Fabs, including five RBD-binding Fabs from three different competition clusters. COVA1-12 overlapped highly with the epitope of COVA2-39, whereas COVA2-04 approached the RBD at a different angle somewhat similar to that of the cross-binding SARS-CoVspecific mAb CR3022 (42). The EM reconstructions confirmed the RBD as the target of these NAbs but revealed a diversity in approach angles (Fig. 5B). Furthermore, whereas four RBD NAbs interacted with a stoichiometry of one Fab per trimer, consistent with one RBD being exposed in the up state and two in the less accessible down state (13, 43), COVA2-15 bound with a stoichiometry of three per trimer (fig. S7). COVA2-15 was able to bind RBD domains in both the up and down state (Fig. 5D). In either conformation, the COVA2-15 epitope partially overlapped with the ACE2-binding site, and therefore the mAb blocks receptor engagement. The higher stoichiometry of this mAb may explain its unusually strong neutralization potency. None of the epitopes of the five RBD Fabs overlapped with that of CR3022, which is unable to neutralize SARS-CoV-2 (42), although COVA2-04 does approach the RBD from a similar angle as CR3022. The sixth Fab for which we generated a three-dimensional (3D) reconstruction was from the non-RBD mAb COVA1-22 placed in competition cluster IX. EM demonstrated that this mAb bound to the NTD of S1. Such NTD NAbs have also been found for MERS-CoV (44).

Convalescent COVID-19 patients showed strong antiSARS-CoV-2 S proteinspecific B cell responses and developed memory and antibody-producing B cells that may have participated in the control of infection and the establishment of humoral immunity. We isolated 19 NAbs that targeted a diverse range of antigenic sites on the S protein, of which two showed picomolar neutralizing activities (IC50 = 0.007 and 0.009 g/ml or 47 and 60 pM, respectively) against authentic SARS-CoV-2 virus. This illustrates that SARS-CoV-2 infection elicits high-affinity and cross-reactive mAbs targeting the RBD as well as other sites on the S protein. Several of the potent NAbs had VH segments virtually identical to their germline origin, which holds promise for the induction of similar NAbs by vaccination because extensive affinity maturation does not appear to be a requirement for potent neutralization. The most potent NAbs both targeted the RBD on the S protein and fell within the same competition cluster, but were isolated from two different individuals and bore little resemblance genotypically. Although direct comparisons are difficult, the neutralization potency of these and several other mAbs exceeds the potencies of the most advanced HIV-1 and Ebola mAbs under clinical evaluation, as well as the approved anti-RSV mAb palivizumab (45). Through large-scale SPR-based competition assays, we defined NAbs that targeted multiple sites of vulnerability on the RBD and the additional previously undefined non-RBD epitopes on SARS-CoV-2. This is consistent with the identification of multiple antigenic RBD sites for SARS-CoV-2 and the presence of additional non-RBD sites on the S protein of SARS-CoV and MERS-CoV (32). Subsequent structural characterization of these potent NAbs will guide vaccine design, and simultaneous targeting of multiple non-RBD and RBD epitopes with mAb cocktails paves the way for safe and effective COVID-19 prevention and treatment.

Original post:
Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability - Science Magazine

How to avoid back and neck pain while working from home – TODAY

Is working from home a literal pain the neck? Many of us have spent long hours hunched over impromptu workstations on beds, coffee tables and kitchen islands since the onset of the pandemic. With elevated stress levels, fewer opportunities for movement and upended routines, working from home can be a recipe for back and neck pain.

Chiropractors specialize in correcting misalignments of the neck, back and head through careful manipulations of the spine. But since many of us dont have access to a chiropractor in person, here are some tips to help you reduce back and neck pain while working at home.

How can you maintain good posture while working from the kitchen table? Andrew Bang, D.C., lead chiropractor at the Center for Integrative Medicine at The Cleveland Clinic, recommends this checklist to properly position your head, arms and back.

Bang and Barbara Rosinsky, a chiropractor in Wantagh, New York. recommended these seven simple tips to keep you free of back or neck pain between visits.

Belly snoozing is the worst position to sleep in, said Rosinsky. You have to turn your head to the left or right, and that creates neck strain, she says. Instead, either sleep on your back with pillows under your knees or on your side with pillows between your knees. Both positions help maintain the spines natural curvature. In both positions, sleep with a small pillow under your head and pull the pillow down so its also supporting your neck, Rosinsky explained.

Trending stories,celebrity news and all the best of TODAY.

Strong abdominals are key to reducing pain in your back, but if you have back pain, traditional crunches and sit-ups actually make the pain worse, Bang explained. Instead, hold yourself in a yoga plank pose lie on your stomach and then lift your body so youre balancing on your hands and your toes, like a push up. Hold the position as long as you can, increasing the time with each attempt.

Side planks will also firm up your core. From the plank position, rotate your body to the left so you are balancing on your outstretched left arm and on your left foot (either stack your right foot on top of your left or place your right foot down if it's necessary for balance). Reach your right arm upward. Hold it as long as you can and then switch sides.

I have more low back pain patients who sit at desk all day than are manual laborers, said Bang. Our hamstrings get locked up from spending so many hours sitting in a chair, Bang explained. So when we try to stand up from sitting, our hamstrings pull on our pelvis, causing misalignments in the spine and all kinds of pain."

But a few simple stretches can counter this effect. While lying on your back, wrap a yoga belt around your foot and pull your leg up, keeping it straight. Feel the stretch along the back of your leg. Then try to stretch your leg across the groin over the left leg to right and vice versa and then out and away from your body towards your hips and. Work yourself up to holding the stretches for 90 seconds.

Take a look at your phone. Notice what you just did? In all likelihood your chin went to your chest and your neck curved into a C-shape. Thats really bad for your neck, said Bang. Theres 12-15 pounds of weight in the human head. The further the head is away from our shoulders looking down at our smartphones, [the more it] strains the muscles. The bones and the discs start to mash together and you get pain. This goes for all handheld electronics, like iPads. To save your neck, prop up your arms so youre looking at your phone straight on. If youre using an e-reader in bed, hold it up on your bent knees instead of down on your lap.

This is going to be a hard one. If you sit at a desk all day, make sure your feet are parallel and planted firmly on the ground, says Rosinsky. If your feet dont reach the ground, use a box or foot rest to prop them up. This will reduce pressure on your lower back. Also remember to raise your computer screen so its at eye level to limit neck strain.

When your grandmother scolded you about slouching, she was doing more than trying to make you look better. She was likely saving you from a backache. Sit up on your sit bones, not back on the sacrum, says Rosinsky, referring to the fleshier part of your tush. Think about the curve in your lower back and try to preserve it as you sit. And whatever youre working on, your keyboard and your computer screen should be square with your body. So dont put your laptop on your lap and hunch over it. Youre much better off putting it on a table.

Too much time spent in any one position sitting or standing can trigger back pain. The more active you are, the more you stretch out your muscles and get your body accustomed to physical activity so you're the less likely to suffer pain, Bang explained. You need to eat well, drink well and move well, he says. If you get too sedentary you will have more pain.

All of these strategies can help you stave off pain, but chiropractors also recommend regular adjustments that can help keep the spine aligned, the nervous system functioning properly and reduce the risk of recurring pain. When the situation allows, seeing your chiropractor on a regular basis, whether youre in pain or not, will help you maintain your balance and your range of motion, Bang said.

A version of this story originally appeared on iVillage.

Continued here:
How to avoid back and neck pain while working from home - TODAY

Eclipse season is underway, and its a welcome time to check in with personal values and grow – Well+Good

This week, June (and Gemini season) comes into full swing as the astrological intensity of 2020 continues. Weve already witnessed the game-changing power of this years transits with the historical alignment between Saturn, Jupiter, and Pluto in Capricorn that happened in mid-March at the onset of the COVID-19 breakout in the United States. Its safe to say that the cosmic backdrop to this year correlates with global transformation.

Now that we are officially in eclipse season, amid Venus retrograde, with Mercury in his retrograde shadow, too (Mercury stations retrograde on June 18), we see no signs of this intensity letting up. But intensity can also make way for positive change: With a massive social-justice movement afoot right now, we are collectively being called to make change and globally heal by understanding the connection between our values, our societal ethos, and our health.

As the wellness consultant and social worker, Minaa B., LMSW, stated so eloquently in a recent Instagram post, Healing is not just a good vibes only chant, its a social-justice issue. Healing goes beyond the inner work we do for ourselves; it extends to our community.

View this post on Instagram

bringing this back: I come across a lot of comments, emails and DMs from folks on what it means to do the work, and the reality is that doing the work is such a vague concept and it is much more complex than we like to admit. To do the work, requires self-healing, but healing is not just limited to you as an individual, it extends to the people around you, and it even extends to a macro-level when it comes to systems and institutions, who we vote for, how we exercise our rights and how we treat others. I hate talking about what it means to do the work sometimes because the reality is the work I need to do to heal will look completely different from other folks because none of us are equal no matter how hard we want act like we are. I am a black woman living in America. Just sit with that for a second and really ask yourself if you think my healing will look the same as white man or womans. The work I have to do to heal and the work you have to do to heal just isnt the same. Ive noticed that insta-therapy has created this idea that feeling through our emotions is how we get better. With no talk about how fighting injustice is a crucial role in helping us move from a role of surviving versus thriving. Healing is a social justice issue. It requires tackling issues from sexism to racism, all the way to redlining and health inequity. I encourage you to think broader when it comes to your healing because this is how we shift generations. Healing can happen for all of us, but it doesnt stop at us. When we thrive, our communities thrive. And community care should not be isolated from self-care. I wont tell you how to do the work. But I encourage you to look beyond yourself as you heal.

A post shared by Minaa B., LMSW (@minaa_b) on Jun 3, 2020 at 6:30am PDT

Lets break this down by beginning to understand what Venus recent conjunction with the sun means. Venus represents what we love and why we love it. Currently retrograde in Gemini, Venus aligned with the sun at 13 degrees on June 3 in the sign of the twins at 1:43 p.m., ET. When retrograde, Venus calls our attention to where we are and where we are not congruent with the ethics that guide our lives. Venus alignment with the sun last week allowed us to start a new cycle of growth as it relates to honoring our values.

How have your values made themselves more apparent in your life over the last few weeks? What have you learned? What do you need to shed or release to be more congruent with your values as they evolve? What truth do you need to own for yourself?

The interplay between astrological events and current events beckons introspection, action, and soul-driven choices.

While I was studying behavior change at Duke Integrative Medicine in pursuit of my health coach certification, I learned that having a clear connection with our values is fundamental to our health. And now, the interplay between astrological events and current events beckons introspection, action, and soul-driven choices. I see this current Venus retrograde cycle (through June 25) and the planets recent inferior conjunction with the sun in Gemini as calling us to realign with the truth emerging from within as we face the systemic challenges of the society in which we live.

With eclipse season shining a light on truths in the shadows, we can begin to understand that these truths are essential to living our healthiest lives as individuals and society.

Eclipse season kicked off at 15 degrees of Sagittarius (the sign of blunt truth) on June 5. This south node, lunar eclipse asked us to release old patterns and behaviors that no longer serve us, so we can let a new truth emerge. The lunar eclipse in Sagittarius asks us to get into touch with the philosophies that guide our lives and make space for the evolution of new viewpoints. Doing so serves both our individual and our collective freedom. Freedom is a quintessential aspect of lessons of Sagittarius.

With the moon now waning, its imperative to continue the cathartic work of grieving and integrating the new truths emerging from within during this eclipse season, with a solar eclipse happening on the summer solstice in Cancer, as well as a lunar eclipse on July 4/5 (depending on your time zone). Please do the work you need to take care of yourself, as eclipses can feel incredibly disruptive and disorienting, even more so if they occur at critical placements in your chart. So, take time and rest. Nourish yourself. Exercise. Drink plenty of water. Tend to your pleasure.

Remember, we are still in a pandemicyour immunity matters. In in the face of digesting and responding to difficult news, its essential to reconstitute yourself and bolster your resilience as often and as much as you can. Thankfully, the cosmic dance grants us a moment to regroup on Monday and Tuesday, so use it to your advantage. Spend time meditating, in prayer, reading up on anti-racist education, and unpacking privilege.

As the week goes on, well contend with the impact of the sun in Gemini squaring Neptune in Pisces. This mutable square may feel particularly intense. (The sun officially squares Neptune on Thursday, June 11 at 5:37 a.m., ET.) Even more so, since Mars conjoins Neptune, too. (The Mars/Neptune conjunction perfects on Saturday the 13th at 10:12 a.m., ET.) To help you through, a meditation practice canhelp you gain perspective, reduce stress, and bolster resilience.

Your health and the health of the collective, by proxy, will benefit from self-care practices right now. Remember, honoring your evolving values supports you to ride the waves of this volatile year, astrologically and otherwise, and make the impact in the world you are here to create.

Jennifer Racioppiis the creator of Lunar Logica philosophy that integrates the deep wisdom of both science and spirituality, and blends her expertise in astrology, positive psychology, and womens healthto coach high-achieving female entrepreneursto reach their next level of success.

Excerpt from:
Eclipse season is underway, and its a welcome time to check in with personal values and grow - Well+Good

What Are the Treatment Options for Migraine? – HealthCentral.com

On this page:BasicsAcute vs. Preventative TreatmentMedicationsMedical DevicesPrevention OptionsLifestyle Changes & Complementary Care

The migraine you had last time is not necessarily the one youll have again. Your new attack might start with you seeing zigzags, getting tunnel vision, or feeling a tingle in your hands before a throbbing painful headache starts 20 minutes later. Or you just might get a headache thats bad enough to send you to bed with the shades drawn.

And just as all attacks can differ, so can every treatment plan. Your doctor will go over your migraine history and offer recommendations based on the type of migraines you have, how many attacks you have a month, recent research, and their own experience. There are many more options now than even just a year or two agomore preventative treatments and more meds to stop attacks, and even some alternative methods that are backed by science. This overview of potential choices can help you get a clearer picture of what you can do to stop the pain.

Think of migraines as a brain disease. Thanks to a strong family history (your mom or dad probably had attacks, too), youve inherited a brain thats super-sensitive to certain triggers that set off a cascade of changes in different parts of the brain.

While experts dont know for sure the exact interplay between the neural pathways and chemicals that produces the symptoms of migraines, they think that the hypothalamus, the part of the brain that regulates many of the bodys functions, and the brain stem are involved. At the beginning of an attack, these areas start to communicate with one another in an abnormal way. As the nerves in these areas start to fire more and more, they release chemicals that cause inflammation and dilate the blood vessels, producing pain.

These attacks happen at least once or twice a month for the 39 million people in the U.S. who have migraines. About 10% have attacks several times a month. Another 8% have them more than 15 times a month. Three times as many women have migraines than men. But even little kids can have them.

Basically, there are two types of treatmentthe type that prevent attacks, or at least lower the number and intensity (known as preventative); and treatments that you take during an attack (known as acute). These include oral meds as well as injections and non-drug devices. There are also complementary treatments that include supplements and lifestyle changes that help keep triggers at bay.

Most of these, except for one exception, work for every kind of migraine patient. A doctor will diagnose you with episodic migraines if you get fewer than 15 attacks per month. Chronic migraine patients are those who have more than 15 attacks.Sadly, both types of migraine patients dont get the help they need. When they surveyed people with migraines in 2016, researchers discovered that fewer than half (40%) were seeing a provider for their migrainesand only a quarter of those folks had gotten an accurate diagnosis with the right treatment. The American Migraine Prevalence and Prevention Study, which also surveyed those with migraines, found that while 98% took medications during an attack, only one in five took drugs that could prevent migrainesand the majority of those discontinued using those preventative treatments because of side effects.

Doctors found that for many people with migraines the best treatment involves preventative remedies along with medications that you can take during an attack. And luckily, in the past two years, a number of new drugs that target specific pain receptors have become available to migraine sufferers. There are also non-drug devices that are also new to the market. Your best bet for the right treatment is to go to a dedicated headache specialist or clinic to find relief (you can find a list at Migraine Research Foundation). But there arent that many specialists, so you may get help if you see a neurologist or get referred to one from your primary care provider.

There are more options than ever, and they include drugs ranging from ordinary pain relievers to newer, more targeted injectable drugs. If you cant take these medications, then there are non-drug devices you can try. Usually, doctors will recommend taking only acute treatments to people with episodic migraines, especially if they only have one or two attacks per month.

You take acute medications at the first signs of a headache, not during the aura (if you are one of the 20% people with migraines who have them). Ideally, any treatment you use to stop a migraine should work in two hours or lessand your pain shouldnt come back later (even a day later). If thats not the case, its time to switch medications (or move on to preventative ones).

These are the drugs most migraine patients end up taking, but they work best if you dont have many attacks and the pain isnt that bad. Theyre usually sold over-the-counter (OTC), though sometimes a doctor can write an Rx for stronger doses. Take them soon after the headache begins, but dont take more than the recommended dose in a day, and skip them if you have two or more headaches a week.

The reason: People can get rebound headaches when these OTC drugs are overused, which then can be difficult to treat. Plus, taking too many NSAIDs like Advil (ibuprofen) could put you at risk for such gastric issues as bleeding or ulcers, which people with migraines are three times more likely to get. So if youre popping over-the-counters like candy, ask your doctor about prescription options (including preventative meds).

OTC pain relievers include:

If your migraines are getting more frequent and intense and your OTC drugs arent helping, your doctor might recommend a triptan, which activates serotonin receptors in your brain. Experts think abnormal levels of serotonin, a brain chemical that helps your brain cells communicate with one another, may make you more sensitive to pain (as well as depression). Serotonin may also help activate another chemical called CGRP, which is released during a migraine attack.

Triptans come in tablets, nasal sprays, and dissolving tablets, and you take them as soon as you feel a migraine coming on. They usually work in about 30 to 60 minutes, and theyve been found effective in about half to 80% of all migraine patients. They can make your queasy feelings worse (or bring them on) and theyre not recommended for people with high blood pressure, those who suffer from hemiplegic migraines, during pregnancy, or for those with Raynaud syndrome. You can also rely on them too much if youre a chronic migraine sufferer and make things worse.

These drugs include:

If triptans dont work for you, your provider might put you on these drugs, which work by constricting the blood vessels in the brain. Again, you take them at the first signs of an attack. Ergot alkaloids do have side effects (like nausea and vomiting), and you cant take them if youre pregnant or breastfeeding, have heart disease, chest pains, or have a risk of strokes, since they can raise that risk.

These drugs include:

CGRP is a peptide (a small protein molecule) that attaches to nerve endings in the brain responsible for transmitting sensory information, and when you have an attack, its levels increase.

These meds target the CGRP receptors, blocking the protein from attaching to the nerve endings. They come in tablets and typically provide relief within two hours from both pain and symptoms like nausea and light sensitivity for roughly 60% of people.

One in five migraine patients, according to clinical studies, were completely free from pain. The drawbacks? These drugs are expensive, and in order to get insurance to cover them, you have to have tried (and failed) older drugs (like triptans). The side effects include nausea and fatigue but just about anyone who has episodic or chronic migraines, including those with cardiovascular issues, can take these drugs.

Neuromodulation devices are machines that you use at home when you cant (or dont want to) take medications, and they all work by stimulating neural pathways in the brain to relieve pain. Women who are pregnant or trying to conceive as well as older folks who cant tolerate drugs or those who cant tolerate side effects are all good candidates for these at-home devices. These at-home machines have no side effects and sometimes can be used to prevent attacks as well as stop them, no matter what type of migraine you have. The drawbacks? Theyre not covered by health insurance unless youre a veteran and get your health coverage through the Veterans Administration.

They include:

Cefaly (transcutaneous electrical nerve stimulation)It looks a bit like a heart monitor that attaches to your forehead via a sticky electrode. Its used for both prevention and during an attack and works by buzzing the forehead and stimulating the nerves that go into the brain. When you feel a migraine coming on, you put it on and leave it for an hour. One small study found that it cut pain by more than half (57%) after one hour, and none of the patients needed to take other meds. This device costs $550 to buy, and about $25 every three months to replace the electrodes.

sTMS-mini (single-pulse transcranial magnetic stimulation)This device is about the size of a shoe and contains a magnet. You place the sTMS-mini at the back of your head, turn it on, and the magnet pulses four times, stimulating the electrical activity in the brain. Its used both for prevention and during an attack. A study published in the Lancet found that more than one-third of patients were pain free after two hours. Only a doctor can prescribe the sTMS-mini, and the costs are hefty$250 a month to rent (you may get a break through the manufacturer).

GammaCore (non-invasive vagal nerve stimulator)It looks like an electric razor and you place it on your neck for two minutes at a time, about two or three times in a row (so for about four to six minutes total), when you have a migraine. GammaCore stimulates the vagus nerve, which runs from the brain through your face and neck down to your abdomen, blocking pain signals. More than a third of patients are pain-free in an hour and many cut down the number of attacks per month. It too is costly$600 a month to recharge it (and you need an Rx to do it).

NerivioThis high-tech option is only good for those with episodic migraines. It includes a patch that you wear on your upper arm thats controlled via a smartphone app. You turn on the device within 60 minutes of an attack and it sends signals to the brain stem to block you from feeling pain. The sooner you turn on the device, the greater the pain relief, a study published in Neurology found: For those whod used Nerivio within 20 minutes of symptoms, 58% reduced the pain of the attack by half, and about 30% were pain free in two hours. The patch costs $99, and it can treat 12 attacks.

All of the following medications are taken to lower the number of attacks you have a month and, with any luck, make them less severe. Doctors prescribe them to anybody who has migrainesepisodic or chronic, with auras or without. Usually, you want to use them if you have more than four attacks per month or theyre super debilitating.

Just be aware that even with preventative meds or devices, youll need to take something else during an attack. So, for instance, if you decide on Botox shots, youll probably have fewer episodes a month, but youll probably need a triptan or some other pain reliever when you do get a migraine.

Off-label drugs. Sometimes doctors will prescribe drugs that are meant for other things to prevent headaches. You take these pills every day to stop the frequency of attacks. The problem is that these drugs come with some serious side effects, like fatigue, depression, or loss of libido, so people tend to stop using them after a while.

Birth control pills will prevent a quick drop in estrogen and are given to women who have attacks right before or during the periods. These arent the best choice for women who have migraines with auras, because their risk of stroke goes up four or five timesand if theyre on birth control it goes about seven times. And if you smoke, the risk goes up nine times, which is why most doctors wont recommend them if you have auras.

Anti-depressants that raise serotonin levels, like Elavil (amitriptyline) and Effexor (venlafaxine)

Blood pressure medications that can constrict blood vessels, like Inderal (propranolol) and Lopressor (metoprolol)

Anti-seizure medications that can work on glutamate receptors and block excessive, another neurotransmitter involved in migraine auras, like Topamax (topiramate)

Botox shots. The same injections that can make your forehead smoother and erase lines can also prevent migrainesalthough they are only approved for people with chronic migraines. A doctor injects Botox at several points around your head and neck (as many as a dozen or even more). The toxin blocks the release of chemicals that cause pain. Each set of injections last about 12 weeks.

CGRP-binding drugs. These preventative injections are designed to lower the number of attacks you have a monthcutting them at least by half for 50% of patients in clinical studies done on these drugs. They are designed to bind to CGRP molecules and block them from attaching to the receptor. You take these medications once a month, and you can get the shot at the doctors office or give it to yourself (after your provider shows you how). The side effects include pain and redness at the injection site (typically your thigh or stomach), nausea, and constipation.

The headaches are also less severe, so patients in studies reported a better quality of lifemissing fewer days at work, not having to skip family or social events, having less trouble concentrating and feeling exhausted.

These meds include:

Two of the same at-home brain stimulating devices that can treat your migraines can also reduce the number of migraine days if you use them for prevention as well.

CefalyTurn it on every evening for 20 minutes. One small study found that the number of attacks dropped from an average of seven a month to slightly fewer than five.

sTMS-miniGive yourself four pulses in the morning and four pulses at night for prevention. One study found that about 46% of patients cut the number of migraines by at least half.

Along with medical treatments, you can also try tweaking your diet and other parts of your life that may be triggering attacks, like insomnia or stress.

Getting better sleep. Insomnia as well as other sleep disorders like sleep apnea have been linked with migraines, both as triggers and as another accompanying chronic condition. If you wake up with headaches, the quality and quantity of sleep may be to blame. A doctor may work with you to get you on a sleep schedule (going to bed and waking up at the same time) as well as other aspects of sleep hygiene (like, say, keeping your bedroom cool or keeping your phone on the other side of the room). Or connect with a therapist who can teach you specialized cognitive behavior therapy strategies designed to help you fall asleep and stay that way more easily.

Eat healthier foods. There is some evidence to show that obesity can turn episodic migraines into chronic ones. Theres no one anti-migraine diet, but try to eat more plant-based meals and swap out unhealthy foods like soda and sugary treats for more fruits and veggies. And keep to a regular eating schedule to keep blood sugar fairly even. One trigger for many people is skipped meals or going too long before eating.

See an acupuncturist. You can lop off an average of three-and-a-half days of migraine attacks with 20 sessions of acupuncture, according to Chinese researchers. The caveat: This small study was done on people with episodic migraines without auras. Either way, the therapy can be very relaxing, and theres nothing wrong with having an excuse to lie quietly in a comfy, dark room.

Try magnesium supplements. If you want to prevent migraines from happening and arent keen on spending money on devices or other drugs, try taking 400 to 500 mg of magnesium oxide every day. It works best on those who have migraines with aura as well as people who have auras but have no or very mild headaches after their aura signs. Magnesium can block a receptor in the visual processing part of the brain thats activated by glutamate, the area in the brain most implicated in auras.

Other supplements that may help (or at least are worth a discussion with a provider):

In studies, each of these supplements were found to cut down the frequency of migraines perhaps because of their anti-inflammatory, antioxidant properties. Melatonin can also help you sleep better, which can also help cut down the number of attacks, and it may also block CGRP release, which helps lessen the pain. Some of these supplements even come in combo form, like Dolovent (magnesium, coenzyme Q10 , and B2).

Manage your stress. Like sleep, people with migraines are stressed and have anxiety, and that may lead to other unhealthy coping strategies like smoking, taking too many medications, and over-eating. So it makes sense that anything that can get you to relax will be good for your overall health as well as your migraines. There have been a few evidence-based techniques that can work to reduce migraine pain as well as frequency, including cognitive behavior therapy (CBT), whether online or group sessions, as well as mindfulness techniques, which also work well for those people whose migraines have gotten worse because they over-use medications. Theres also some evidence to show that doing yoga can also cut down the number of attacks and the intensity of migraine pain.

The answer (like all answers): It depends. There are newer drugs that have just been approved that target specific brain chemicals thought to be responsible for producing migraine pain. These drugs come in the form of monthly injections, but in order to get an Rx, you have to have tried other medications that ultimately failed for you. There are also at-home devices that have fewer side effects and are good for people who dont want to take medications (or whose meds havent worked).

Yesand those range from brain-stimulating devices like the Nerivio patch/app for people with episodic migraines to magnesium supplements for those who have migraines with auras. You could also try acupuncture, yoga, mindfulness meditation, and even cognitive behavioral therapy. All of those have some science-based evidence to show that they can cut headache pain and frequency.

Yes, but this treatment is only approved for people who suffer from chronic migraines. You need to get a series of injections every three months or so.

If you have several migraines a month, especially if they are debilitating, you might want to consult a doctor about adding a preventative treatment to your pain relief regimen. That could be as simple as taking extra supplements (like melatonin that can help you sleep better and block the pain-producing CGRP), or getting an Rx for injections that can cut the number of migraine days or a brain-stimulating device that works to prevent migraines as well cut the pain during an attack.

Migraine Treatment Statistics: National Headache Foundation. (n.d.). Statistics from the American Migraine Prevalence and Prevention Study, headaches.org/2011/04/08/statistics-from-the-american-migraine-prevalence-and-prevention-study/

Migraine Treatment Overview: Pain Treatment and Research. (2015). Evidence-Based Treatment for Adults With Migraines. ncbi.nlm.nih.gov/pmc/articles/PMC4709728/

Problems With Migraine Care: Headache. (2016). Assessing Barriers to Chronic Migraine Consultation, Diagnosis, and Treatment: Results From the Chronic Migraine Epidemiology and Outcomes (CaMEO) Study. ncbi.nlm.nih.gov/pubmed/27143127

CGRP Targeted Treatments: Institute for Clinical and Economic Review. (2020). Acute Treatments for Migraine: Evidence Report. icer-review.org/wp-content/uploads/2019/06/ICER_Acute-Migraine_Evidence_Report_011020_updated_011320

Cephaly Device and Pain Relief: Neuromodulation. (2017). External Trigeminal Nerve Stimulation for the Acute Treatment of Migraine: Open-Label Trial on Safety and Efficacy. ncbi.nlm.nih.gov/pubmed/28580703

sTMS-mini Acute Pain Relief: The Lancet (2010). Single-pulse transcranial magnetic stimulation for acute treatment of migraine with aura: a randomised, double-blind, parallel-group, sham-controlled trial. thelancet.com/journals/laneur/article/PIIS1474-4422(10)70054-5/fulltext

sTMS-mini Prevention: Cephalagia. (2018). A multicenter, prospective, single arm, open label, observational study of sTMS for migraine prevention (ESPOUSE Study). ncbi.nlm.nih.gov/pmc/articles/PMC5944078/

Nerivio and Pain Relief: Neurology. (2017). Nonpainful remote electrical stimulation alleviates episodic migraine pain. n.neurology.org/content/88/13/1250.short

Lifestyle Interventions: Cleveland Clinic Journal of Medicine. (2019). SEEDS for Success: Lifestyle Management in Migraine. ccjm.org/content/86/11/741

Magnesium Supplements: American Migraine Foundation. (2013). Magnesium. americanmigrainefoundation.org/resource-library/magnesium/

Integrative Medicine and Migraines: Current Headache and Pain Reports. (2019). Complementary and Integrative Medicine for Episodic Migraine: an Update of Evidence from the Last 3 Years. ncbi.nlm.nih.gov/pubmed/30790138

Yoga and Migraines: Journal of Physical Therapy Sciences. (2015). Effects of yoga for headaches: a systematic review of randomized controlled trials. ncbi.nlm.nih.gov/pmc/articles/PMC4540885/

Acupuncture and Migraines: BMJ. (2020). Manual acupuncture versus sham acupuncture and usual care for prophylaxis of episodic migraine without aura: multicentre, randomised clinical trial. ncbi.nlm.nih.gov/pubmed/32213509

Read this article:
What Are the Treatment Options for Migraine? - HealthCentral.com

OnlineMedEd Raises $5M From Physician Networks Across the Nation – Benzinga

AUSTIN, Texas, July 6, 2020 /PRNewswire-PRWeb/ --OnlineMedEd, a digital healthcare learning platform, today announced a $5M financing round, raised from more than 20 physicians, founders, and partners of some of the largest physician-owned firms in the United States. The funds will be used to support the expansion of their platform beyond medical school to provide high-quality educational content for the over 60 million healthcare professionals across the globe in specialties ranging from nursing to physician assistants to MD's and DO's.

Today, OnlineMedEd is the clinical learning platform of choice for a broad spectrum of healthcare learners. Over 86% of medical students in the United States are currently using OnlineMedEd to gain the knowledge needed not just to excel in Board exams, but also in clinical practice. In addition to being used by individual med students, OnlineMedEd's suite of products are institutionally used by over 50 universities nationally, and many more around the world.

"Our purpose is to change how medical education is delivered to bring up the quality and performance of the entire healthcare industry," said Jamie Fitch, CEO of OnlineMedEd. "This investment round, raised from highly qualified physicians, further validates the broad demand for OnlineMedEd in the healthcare profession. We're excited to leverage our investors' clinical expertise, professional networks, and business resources as we grow into new markets beyond medical school."

The funding comes at a time when OnlineMedEd is leveraging its education, technology and clinical expertise to support health care professionals beyond medical school in the fight against COVID-19. The company recently launched a Crash Course in Medicine, a suite of 48 free online video lessons aimed at helping redeployed medical professionals get up-to-speed on the medical knowledge they need to confidently provide care in today's environment.

OnlineMedEd has seen an acceleration of adoption since this launch. Prior to the pandemic, they had over 200,000 monthly active users; today, they have over 350,000 monthly active users. In April 2020, the company recorded 27 million minutes of watched video, a more than 100% increase over their healthy baseline of 13 million minutes / month.

"The innovation and reach of OnlineMedEd's comprehensive medical curriculum is exceeded only by the goodwill of their educational mission," says Glenn C. Robinson, M.D., past President of Austin Gastroenterology, P.A. and one of the investors in OnlineMedEd. "The ease and accessibility of its integrative learning tools will be embraced by students and educators alike as a welcomed and timely addition to the traditional learning experience. As an investor, I envision OnlineMedEd's complete solution as merely the DNA base pairs to replicate for the future of all professional education."

In addition to Crash Course, OnlineMedEd provides key learning modules including:

OnlineMedEd was founded in 2014 and is headquartered in Austin, TX. The digital learning platform is currently used in 191 countries.

To learn more about OnlineMedEd, please visit: https://onlinemeded.org.

About OnlineMedEd

OnlineMedEd is a digital healthcare learning platform whose mission is to change how medical education is approached, delivered and learned by healthcare students and institutions alike.

Used in 191 countries and by more than 86% of clinical medical students domestically, the OnlineMedEd learning platform combines technology, education, and data-driven insights to create a comprehensive and personalized experience for its learners, making learning faster, easier, and more reliable. All material is peer-reviewed and developed by physician educators with one goal in mind - making students into better providers.

For more information, visit http://www.onlinemeded.org.

SOURCE OnlineMedEd

Here is the original post:
OnlineMedEd Raises $5M From Physician Networks Across the Nation - Benzinga